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http://www.biomedcentral.com/1471-2318/14/85RESEARCH ARTICLE Open AccessA systematic review of the evidence that brain
structure is related to muscle structure and their
relationship to brain and muscle function in
humans over the lifecourse
Alixe HM Kilgour1,2*, Oliver M Todd2 and John M Starr1,2Abstract
Background: An association between cognition and physical function has been shown to exist but the roles of
muscle and brain structure in this relationship are not fully understood. A greater understanding of these relationships
may lead to identification of the underlying mechanisms in this important area of research. This systematic review
examines the evidence for whether: a) brain structure is related to muscle structure; b) brain structure is related to
muscle function; and c) brain function is related to muscle structure in healthy children and adults.
Methods: Medline, Embase, CINAHL and PsycINFO were searched on March 6th 2014. A grey literature search was
performed using Google and Google Scholar. Hand searching through citations and references of relevant articles was
also undertaken.
Results: 53 articles were included in the review; mean age of the subjects ranged from 8.8 to 85.5 years old. There is
evidence of a positive association between both whole brain volume and white matter (WM) volume and muscle size.
Total grey matter (GM) volume was not associated with muscle size but some areas of regional GM volume were
associated with muscle size (right temporal pole and bilateral ventromedial prefrontal cortex). No evidence was found
of a relationship between grip strength and whole brain volume however there was some evidence of a positive
association with WM volume. Conversely, there is evidence that gait speed is positively associated with whole brain
volume; this relationship may be driven by total WM volume or regional GM volumes, specifically the hippocampus.
Markers of brain ageing, that is brain atrophy and greater accumulation of white matter hyperintensities (WMH), were
associated with grip strength and gait speed. The location of WMH is important for gait speed; periventricular
hyperintensities and brainstem WMH are associated with gait speed but subcortical WMH play less of a role. Cognitive
function does not appear to be associated with muscle size.
Conclusion: There is evidence that brain structure is associated with muscle structure and function. Future studies
need to follow these interactions longitudinally to understand potential causal relationships.Background
Maintaining good levels of brain and muscle function across
the lifespan is crucial to achieving a good quality of life
[1-3]. There is substantial evidence showing an association
between cognition and muscle function [4-8], however the
role of muscle and brain structure within this association is
less well understood. A greater understanding of this role* Correspondence: a.kilgour@ed.ac.uk
1Centre for Cognitive Ageing and Cognitive Epidemiology, University of
Edinburgh, Room F2, 7 George Square, Edinburgh EH8 9JZ, UK
2Geriatric Medicine Unit, University of Edinburgh, Edinburgh, UK
© 2014 Kilgour et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.will help to improve current knowledge of the mechanisms
linking brain and muscle function over the lifecourse.
Several theories have been proposed as to why rela-
tionships between brain and muscle structure and func-
tion may exist. The common cause hypothesis postulates
that there are core common underlying processes which
drive ageing throughout the human body. The construct
was originally described in a paper by Lindenberger and
Baltes in 1994 who noted that measures of visual and
auditory acuity accounted for variance in intelligence in
old age [9]. Since then experiments in caloric restrictionLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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wed down in multiple systems throughout the body by
one intervention [10,11]. However, environmental fac-
tors also impact on how tissues change across the life-
course and another theory by Mitnitski et al. proposes
that the number of environmental stressors experienced
(e.g. disease, smoking) and the ability to recover from
them, vary the level of deficit accumulation experienced
in multiple organ systems, and hence how tissues like
brain and muscle change with age [12]. Potential under-
lying mechanisms include: pro-inflammatory cytokines
(e.g. TNF-alpha and IL-6); the role of glucocorticoids and
their intracellular amplifier 11beta-hydroxysteroid de-
hydrogenase type 1 [13-15]; the role of vitamin D [16,17];
exercise as a way to improve cardiovascular fitness in
addition to its beneficial effect through hormones and cy-
tokines [18-20]; and cellular senescence (e.g. through oxi-
dative stress) [21,22].
In view of these theories, there should be a correlation
between the structure and function of brain and muscle
throughout our lifetime in the absence of significant
pathology. This systematic review will search for studies
that test the hypotheses that brain structure is related to
muscle structure and/or function and that muscle struc-
ture is related to brain function in healthy children and
adults. Previous studies and reviews have looked at evi-
dence relating brain function (e.g. MMSE score) to
muscle function (e.g. walking speed) therefore this sep-
arate but closely related field of literature will not be
included in this review [5,23-25].
Methods
The study protocol was published online in December
2011 at: http://www.ccace.ed.ac.uk/sites/default/files/
Kilgouretal.pdf.
Inclusion criteria
Population
All human subjects regardless of age were included in
the study; from newborn babies to the oldest old, includ-
ing post-mortem studies. This study is examining the re-
lationship between brain and muscle in health, not
within the effects of pathology therefore studies looking
at how a disease affects brain or muscle were excluded.
However studies which included a healthy control group,
where the data from these subjects can be or was ana-
lysed separately were included. As morbidity increases in
frequency with age it would be very restrictive to include
solely those studies which include only participants who
are free from any disease, therefore studies will be in-
cluded provided the subjects have been recruited in a
way that did not pre-dispose to morbidity being more
prevalent than in the general population (e.g. from a dia-
betes clinic).It was planned that subgroup analysis would be
undertaken where possible and would include data be-
ing extracted to investigate the effects of gender, age,
socioeconomic status and ethnicity.
Interventions/Comparators
Not applicable as the study is investigating normal
physiology.
Outcomes
Brain structure
 Whole brain volume (WBV) or total brain volume
(TBV)
 Volume or cross sectional area of regions within the
brain (e.g. hippocampus, frontal lobes)
 White matter integrity (e.g. White matter
hyperintensities (WMH) or white matter signal
abnormalities (WMSA)
 Histological findings about brain structure on
autopsy
Brain function
 Any recognised measure of cognitive function
including: memory, attention, executive function,
language and processing speed
 Reaction time will not be used as this is dependent
on aspects of brain and muscle structure and
function
Muscle structure
 Muscle cross sectional area on CT, MRI or USS
 Muscle volume (using CT or MRI)
 Whole body lean tissue mass using DEXA, giving:
total lean mass (TLM) or appendicular lean mass
(ALM)
 Bioimpedance analysis (BIA)
 Histological findings on muscle biopsy or on autopsy
Muscle function
 Any recognised test of muscle strength, including
isometric, isotonic, isokinetic tests
 Any recognised test of muscle power
 Functional tests of muscle function (e.g. usual or
maximum gait speed)
Study design
As this review is studying a physiological relationship, inter-
vention studies were not included, unless they contained ei-
ther a control arm with extractable data with no placebo
treatment or baseline data prior to the intervention.
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sectional studies were included and the control arm of case
control studies. Case reports were excluded as these would
not contain evidence of normal physiological relationships
out with pathology. The only other limiter used was “hu-
man” in Medline, Embase and PsycINFO but not Cinahl as
it appears to screen out human studies erroneously.
Search strategy
Database searches of Medline, Embase, CINAHL and
PsycINFO were undertaken. All languages were included
in the search. The Medline search strategy can be found
in Appendix 1. The searches were all performed on 6th
March 2014. A grey literature search was performed using
Google and Google Scholar. Hand searching through cita-
tions and references of relevant articles was also undertaken.
Study selection
The search was undertaken by two independent re-
searchers. Titles +/− abstracts found using our search
strategy were independently screened for relevance. The
full text of the selected studies was reviewed against the
inclusion criteria, and reasons for exclusion at this stage
were recorded. At this point the two researchers met to
discuss shortlists and discuss any articles which only one
researcher had selected to decide if they should be in-
cluded or not. Disagreements were resolved by consen-
sus or adjudication by a third party (a Professor in
Geriatric Medicine).
Data extraction
The Clinical Fellow (AK) performed the data extraction
using a data extraction sheet written by the Clinical Fel-
low and approved by the two co-authors (OT, JS).
Contacting authors
Of the 84 studies found through our search, we wrote to
79 to request data or associations which were not given
in the text. Five of the studies had given all the associa-
tions for the variables listed in the text. A letter was sent
by email to either the corresponding author (after check-
ing they were still working at the study location) or the
last author (after the same checking process). Only one
author was written to from each study (e.g. all articles
arising from the Kansas Brain Aging Project, were
grouped together when requesting extra data/associa-
tions). After the initial email a further email was sent
around 2 weeks later to act as a reminder. Studies were
given a minimum of around 1 month to reply.
Out of the 79 studies we wrote to: 25 studies (32%)
sent either the requested data or associations; 22 (28%)
replied stating they would try and send the data or asso-
ciations to us but then never did; 12 studies (15%) re-
plied stating they either no longer had access to the dataor did not want to send either the requested data or as-
sociations to us; and 20 (25%) never replied to either of
the emails.
Quality assessment and risk of bias
All papers included in the study had their inclusion and ex-
clusion criteria reviewed to check for possible bias in the
study selection. The topic of the review is not looking at an
intervention, therefore the risk of reporting bias for an in-
dividual paper is small. Also, in most of the papers, the re-
lationship between muscle and brain was not the primary
topic of the paper, further decreasing the risk of reporting
bias. However when contacting the authors, asking for ei-
ther the data or the associations, it was considered that the
studies which replied may show some bias. The authors
may look at their data and only reply if an association was
found, or if they found a strong relationship they may not
want this to be initially reported within a systematic review,
but rather in a paper in its own right. All summary mea-
sures were included (e.g. odds ratio, beta).
Data analysis
A narrative synthesis was completed. It was thought un-
likely that the data would be comparable enough to
allow meta-analysis (i.e. different measures of cognition,
different muscle groups studied using different ma-
chines) and this proved correct. It was hoped that sub-
group analysis would be undertaken, either in the form
of a meta-analysis or more likely as a narrative synthesis
for the reasons mentioned in the above paragraph.
Results
The search results are presented in the PRISMA flow
diagram in Figure 1. Reasons for exclusion of articles
after reviewing the full text are reported in Table 1. After
applying the inclusion and exclusion criteria 84 articles
were identified; 53 articles either reported the appropri-
ate associations or sent us the data or associations re-
quested (Tables 2, 3 and 4), and 31 articles contained
the required data but did not report the association be-
tween them and did not supply either the data or associ-
ations requested (Table 5). Out of the 53 articles which
could be included in the review; 6 contained data on
brain structure and muscle structure (Table 2); 33 con-
tained data on brain structure and muscle function
(Table 3); and 14 contained data on brain function and
muscle structure (Table 4).
Association of brain structure and muscle structure
Of the six articles which looked at the relationship be-
tween brain structure and muscle structure, three were
from the Kansas Brain Aging Project [28-30], and the
others were from Germany, UK and USA, Phoenix
[26,27,31] (Table 2).
Records identified through 
database searching
Medline 7399
Embase 12,191
PsycInfo 885
Cinahl 1766
(n = 22,241)
Additional records identified 
through other sources
(n = 4)
Records after duplicates removed
(n = 18,496)
Records screened
(n = 18,496)
Records excluded
(n = 18,089)
Full-text articles assessed
for eligibility
(n = 407)
Full-text articles excluded
with reasons (see Table 1)
(n = 323)
Studies included in 
qualitative synthesis
(n=84)
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Figure 1 PRISMA flow diagram showing study selection.
Table 1 Full-text articles excluded, with reasons
Reason Number
Selected subjects (e.g. all had hip fracture,
all had dementia etc.)
73
No measure brain or muscle structure 57
Review article, no relevant references 56
No measure muscle structure or function 47
Abstract, no published results within timeframe or
irrelevant
34
No measure brain structure or function 19
Protocol paper, no published results within timeframe 12
Anthropometry only measure of structure 10
Letter or editorial, no results 7
Technique or theory paper 5
Case Report 2
No full text available 1
Total 323
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mine the effects of exercise and cardiorespiratory fitness
on age-related brain changes. Only one of the papers
from this project reported the relationship between
brain and muscle structure [29]: Burns et al. reported a
positive relationship between WBV and TLM (beta 0.20,
p < 0.001) when control and subjects with Alzheimer’s
disease (AD) were grouped together, adjusting for age
sex and intracranial volume (ICV), and they note that
this was driven by WM volume [29]. They state that this
relationship persists in just the control group but do not
give any statistics for this relationship. A General Linear
Model (GLM) was performed on the data from the non-
demented group supplied to us by the study authors
from the Kansas Brain Aging Project [28-30]. WBV, grey
matter (GM) volume and hippocampal volume were not
predicted by TLM adjusting for age, sex and ICV +/−
education. White matter (WM) volume was predicted by
TLM (t 3.12, p = 0.003, partial eta squared 14%) adjust-
ing for age, sex and ICV. Adjusting for total years of for-
mal education only slightly attenuated the results (t 2.99,
p = 0.004, partial eta squared 13%).
Kilgour et al. also looked at older subjects however
they used neck muscle CSA as a measure of muscle bulk
[27]. They found that total neck muscle CSA predicted
17% of the variance in whole brain volume (p = 0.01),but they found no significant association between total
neck muscle CSA and ventricular, hippocampal or cere-
bellar volumes (p > 0.05), adjusting for age, sex, ICV and
NART (a measure of childhood intelligence).
The other two studies looked at younger subjects.
Heymsfield et al. specifically set out to investigate the
Table 2 Studies identified with brain structure (+/− brain function) and muscle structure
Authors Year Country and
dataset
n Study design Mean age (sd) Male (%) Brain structure/Function Muscle structure Associations*
1. Heymsfield
et al. [26]
2012 Germany 260 Cross-sectional
study
M 45.1 (14.9),
F 38.6 (13.7)
43.1 Structure: Brain volume
transformed into mass
using 1.036 g/cm3
DEXA for FFM Study: Linear regression models
found that after adjusting for age
and fat mass, FFM predicted brain
mass in men (beta 0.023, R2 5%,
p = 0.01) and women (beta 0.003,
R2 6%, p = <0.0001).
Function: not measured
2. Kilgour et al. [27] 2013 UK, MacLullich
Healthy Elderly
Men Study
51 Longitudinal
ageing study
73.8 (1.5) 100 Structure: Whole brain,
hippocampal, ventricular,
cerebellar volumes and ICV
Neck muscle CSA
on MR head scan
Study: Total neck muscle CSA was
found to predict 17% of the
variance in whole brain volume
(t = 2.86, p = 0.01). However, total
neck muscle CSA did not significantly
predict the variance in ventricular,
hippocampal or cerebellar volumes
(p > 0.05). Total neck muscle CSA
did not significantly predict variance
in either the memory factor or the
cognitive processing factor (p > 0.05),
however, it did predict 10% of the
variance in the NART score (t =−2.12,
p < 0.05). Adjusting for age, sex, ICV
and NART where appropriate.
Function: 9 tests of cognitive
function reduced to 2 factors
(cognitive processing factor
and memory factor)
3. Wetmore
et al. [28]
2011 USA, Kansas,
Brain Aging
Project
60 2 year observational
case–control study
(Alzheimer’s dementia
vs. non-dementia)
73.0 (7.2) 43.4 Structure: MRI for WM,
GM, CSF, WBV and ICV
DEXA for lean mass
andASM (just arms
and legs)
Study: none
Function: Logical Memory
I & II, Free & Cued Selective
Reminding Task, Boston
naming test, Verbal fluency,
Digit span forward and
backward, Letter-number
sequencing, Trail making
A & B, Stroop color-word
test and Block design, MMSE
Calculated: Non-demented group
only. WBV, GM volume and
hippocampal volume not predicted
by TLM adjusting for age, sex and
ICV +/− education. WM volume was
predicted by TLM (t 3.12, p = 0.003,
partial eta squared 14%) adjusting
for age, sex and ICV. TLM did not
significantly predict global cognitive
score or MMSE, adjusting for age
and sex. Adjusting for height and
education did not affect this.
4. Burns et al. [29] 2010 USA, Kansas,
Brain Aging
Project
70 Cross-sectional
case–control
study (Alzheimer’s
dementia (AD) vs.
non-dementia)
73.3 (7.3) 42.9 Structure: MRI for WM, GM,
CSF, WBV and ICV
DEXA for total
lean mass
Study: Positive relationship between
WBV and TLM when control and
AD subjects grouped together
(beta = 0.20, p < 0.001), adjusting
for ICV, age and sex. This appears
to be driven by WM (beta 0.19,
p < 0.001) rather than GM (beta 0.06,
p = 0.27) States this persists in just
the control group but doesn’t give
any statistics for this. Positive
relationship between MMSE and
global cognitive score (composite
Function: Logical Memory
I & II, Free & Cued Selective
Reminding Task, Boston
naming test, Verbal fluency,
Digit span forward and
backward, Letter-number
sequencing, Trail making
A & B, Stroop color-word
test and Block design, MMSE
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Table 2 Studies identified with brain structure (+/− brain function) and muscle structure (Continued)
of the cognitive tests) and lean
mass when grouping AD and
control subjects together. States
that controlling for dementia status
attenuates these results, but no
specific statistics given. Calculated:
See Wetmore et al. (2011) for Kansas
Brain Aging Project data analysis.
5. Honea et al. [30] 2009 USA, Kansas,
Brain Aging
Project
56 healthy
controls
Cross-sectional
case–control
study (Alzheimer’s
dementia vs.
non-dementia)
73.3 (6.2) 41.1 Structure: MRI for GM, WM,
CSF, WBV, hippocampal and
parahippocampal volumes
DEXA for total
lean mass
Study: none
Function: MMSE Calculated: See Wetmore et al.
(2011) for Kansas Brain Aging
Project data analysis.
6. Weise et al. [31] 2013 USA, Phoenix 76 Cross-sectional
study
32.1 (8.8) 31.6 Structure: MRI brain
volumes (GM, WM, CSF,
regional GMV)
DEXA, FFMI
(FFM/height2)
Study: Fat-free mass index (FFMI)
was negatively associated with
GMV of the bilateral temporal
lobes, ventromedial prefrontal
cortex (vmPFC) (mainly subgenual
portion of the ACC) and
caudolateral orbitofrontal cortex
and unilaterally with the left insular
cortex (all p < 0.01). After adjusting
for percentage body fat and fat
mass, negative associations of FFM
with GMV of the right temporal pole
and bilateral vmPFC remained. All
models adjusted for age, sex and
handedness.
Function: not measured
*Associations column key: Study = results published within the study; Calculated = study authors supplied raw data to us and we performed the analysis.
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Table 3 Studies identified with brain structure and muscle function
Author Year Country and
dataset
n Study design Mean age (sd) Male (%) Brain structure# Muscle function Associations*
Brain structure and grip strength
1. Sachdev
et al. [32]
2009 Australia, PATH
through life
project
432 Observational
cohort study
M 62.61 (1.42)
F 62.62 (1.44)
52.8 Volumes of GM, WM and
CSF, ICV and TBV (GM
plus WM). Brain atrophy
and subcortical atrophy,
WMH
Grip strength
in writing hand
Study: Total brain WMH volume
predicted grip strength in men
(beta −0.140, delta R2 0.019,
p < 0.05) but not in women
(beta −0.140, delta R2 0.018,
p > 0.05).
2. Anstey
et al. [33]
2007 Australia, PATH
through life
project
432 Observational
cohort study
62.63 (1.43) 51.6 Total, anterior, midbody
and posterior corpus
callosum (CC) area
Grip strength
in writing hand
Study: Grip strength adjusted for
sex and ICV was found to correlate
with CC midbody area (r = 0.103,
p < 0.05), however CC total area
and anterior and posterior CC
areas did not significantly correlate
with grip strength (p > 0.05).
3. Sachdev
et al. [34]
2006 Australia, PATH
through life
project
469 Observational
cohort study
M 62.56 (1.44)
F 62.53 (1.47)
51.8 Volumes of GM, WM and
CSF, ICV and TBV (GM
plus WM). Brain atrophy
and subcortical atrophy,
WMH
Grip strength
in writing hand
Study: None, see other articles
from the PATH through life
project for analysis using this
dataset.
4. Sachdev
et al. [35]
2005 Australia, PATH
through life
project
478 Observational
cohort study
M 62.56 (1.44)
F 62.54 (1.47)
52.3 WMH, ICV Grip strength
in writing hand
Study: Total brain WMH significantly
predicted grip strength (beta −0.09,
p = 0.002) adjusted for age, sex
and depression. Correcting for
comorbidity, cognition and brain
atrophy did not attenuate the
results (beta −0.13, p =0.001).
5. Doi et al.
[36]
2012 Japan 110 Cross-sectional
study
75.4 (7.1) 50 GM, WM, CSF, brain atrophy
(measured using healthy
volunteers)
Grip strength Study: A MLR model found that
grip strength is not related to brain
atrophy (beta −0.082 (SE 0.005)
p = 0.54). Adjusting for age, gender,
BMI, education, MMSE, Tokyo
Metropolitan Institute of
Gerontology Index of Competence,
geriatric depression scale and
change in walking whilst dual
tasking. No other associations given.
6. Hardan
et al. [37]
2003 USA, Philadelphia 41 controls Case–control
study
18.6 (8.6) Not given Caudate, putamen and
total brain volume
Grip strength Study: Non-significant trends
showed a negative correlation
between right grip strength and
total caudate volume (r = −0.303,
p = 0.05) and left grip strength
(r = −0.28, p = 0.07) in the control
group. Not corrected for age or
sex. No relationships given for
other measures.
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Table 3 Studies identified with brain structure and muscle function (Continued)
Brain structure and gait speed
7. Piguet
et al. [38]
2006 Australia, Sydney
Older Person's
Study
111 Longitudinal
observational
cohort study
M 85.29 (2.89)
F 85.72 (3.41)
54.5 Cerebellar vermis area,
(V1, V2 and V3 and total),
Cerebellar volume, cerebral
volume and ICV
Timed walk over
5 m, adjusted for
lower limb arthritis
Study: None of the brain size
measures (cerebellar vermis area,
cerebellar volume or cerebral
volume) significantly predicted
timed walk (p > 0.05) after
adjustment for age (but not sex,
as was not deemed to be a
significant contributor after
univariate analyses).
8. Callisaya
et al. [39]
2013 Australia, Tasmanian
Study of Cognition
and Gait (TASCOG)
225 Longitudinal
cohort study
71.4 (6.8) 56.4 ICV, GM, WM-lesion
free, hippocampal
volume, WML
4.6 metre GaitRite
computerized
walkway (preferred
speed)
Study: MLR were performed to
investigate the relationship of
longitudinal change in brain
volumes and gait speed. They
found that white matter atrophy
(beta 0.25 (CI 0.09-0.40) p = 0.001),
greater WML progression
(beta −0.89 (CI −1.75- -0.02)
p = 0.045), grey matter atrophy
(beta 0.25 (CI 0.00-0.19) p = 0.06)
and hippocampal atrophy (beta 0.01
(CI 0.00-0.02) p = 0.006) were all
associated with a greater decline
in gait speed.
9. Srikanth
et al. [40]
2010 Australia, TASCOG 385 Longitudinal
cohort study
72.2 (7.1) 56 WMLV, TBV Gait speed using
4.2 m GAITRite
system
Study: none, see Callisaya et al.
(2013) for analysis using the
TASCOG dataset.
10. Srikanth
et al. [41]
2009 Australia, TASCOG 294 Longitudinal
cohort study
72.3(7.0) 55.4 WMLV, TBV Gait speed using
4.2 m GAITRite
system
Study: none, see Callisaya et al.
(2013) for analysis using the
TASCOG dataset.
11. Elbaz et al.
[42]
2013 France, Three-
city study
4010 Cohort study 73.4 (4.6) 38.4 WML volumes 6 metre walk speed
(usual and maximum)
Study: Logistic regression stratified
by education found that high WML
volumes were not associated with
slow walking speed among highly
educated participants (OR = 0.72),
but were associated with a
2-fold-increased risk of slow walking
speed among those with low
education (OR = 3.19/1.61 = 1.99)
(p interaction = 0.026), adjusted
for sex, age and total WM volume.
Results remained unchanged after
adjustment for height, BMI, and
MMSE score.
Given: WM volume did not predict
walking speed at baseline, adjusted
for age, gender and ICV in a MLR
(p > 0.05, n = 1510), or decline in
walking speed over 7 years,
adjusted for age, gender, ICV and
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Table 3 Studies identified with brain structure and muscle function (Continued)
baseline walking speed, (p > 0.05,
n = 928). A logistic regression
found that WM volume was not
significantly associated with an
increased risk of being in the
quartile with the highest walking
speed decline (p > 0.05).
12. Dumurgier
et al. [43]
2012 France, Three-
city study
1623 Cohort study 73.3 (4.1) 39.5 Regional grey matter
volumes (sensorimotor
cortex; frontal, parietal,
temporal, occipital, and
limbic lobes; insula;
cerebellum; thalamus;
basal ganglia nuclei,
including the caudate
nucleus, putamen and
pallidum) and WMLs
Maximum walking
speed over 6 metres
Study: A linear regression found
that only basal ganglia volume
(beta 0.075 (SE 0.025) p = 0.003)
was significantly associated with
walking speed; driven by caudate
nucleus volume (beta 0.114
(SE 0.024) p < 0.001). All other
regional GM volumes were not
significantly associated with
walking speed. A semi-bayes
model found again only the
basal ganglia volume (beta 0.061
(SE 0.028) p = 0.03) was significantly
associated with walking speed;
driven by caudate nucleus volume
(beta 0.050 (se 0.019) p = 0.007).
There was found to be a linear
relationship between quartiles of
caudate nucleus volume and
faster walking speed (p for linear
trend (0.001). These relationships
were attenuated slightly for total
basal ganglia volume by adjusting
for MMSE and comorbidity plus
smoking but not for caudate
nucleus volume. All models
adjusted for; age, sex, BMI,
education level, ICV, volume of
WMLs and silent infarcts. Given:
See Elbaz et al. (2013) for Three-City
Study data analysis.
13. Dumurgier
et al. [44]
2010 France, Three-city
study
Baseline 3604,
f/u at 4y 1774
Cohort study Baseline 73.4 (4.6)
f/u 71.5 (3.6)
Baseline 38.1%,
f/u 38.4%
WMH volume Maximum walking
speed over 6 metres,
1st and 4th follow up,
mean 7 years
Study: none
Given: See Elbaz et al. (2013) for
Three-City Study data analysis.
14. Soumare
et al. [45]
2009 France, Three-city
study
1702 Cohort study 72.4 (4.1) 39.4 PVH, deep WMH
and total WMH
and total WM
and ICV
Maximum walking
speed over 6 metres,
1st and 4th follow up,
mean 7 years
Study: A significantly lower mean
walking speed was found in those
with a total WMH volume above
the 75th percentile compared to
those below the 25th (Beta −0.026,
p = 0.0003). A similar relationship
was found for both deep WMH
and PVH. A WMH volume greater
than the 90th percentile more
than doubled the risk of decline
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Table 3 Studies identified with brain structure and muscle function (Continued)
in walking speed compared with
subjects with lower volumes of
WMH (OR 2.6 (1.5-4.5), p = 0.001).
This finding was replicated when
looking at PVH but not for deep
WMH volume. Given: See Elbaz
et al. (2013) for Three-City Study
data analysis.
15. Starr et al.
[46]
2003 UK, ABC1921
cohort study
97 Longitudinal
cohort study
78-79years 59.8 WMH in deep/subcortical,
PVH and brain stem,
Fazekas score
Self-paced time to
walk 6metres
Study: A slower 6metre walk test
was associated with increased
brain stem lesions (F 7.11, p = 0.009,
partial eta2 0.070), but not with
WMH (deep) (F 3.33, p = 0.071)
or PVH (F 2.47, p = 0.12). Doesn’t
state if age and sex are adjusted for
in these models. If HADS score
and Raven’s score are adjusted
for, brainstem lesions are no
longer significantly associated
with walking time.
16. Manor
et al. [47]
2012 USA, Boston, 89 in control group Case–control
study
65.3 (8.2) 48.3 GM, WM, CSF, regional
GM volumes; precentral
and postcentral gyri, basal
ganglia, cerebellum, and
dorsolateral prefrontal
cortex
75 metre walk test
at preferred pace
Study: Within linear regression
models, global GM volume and all
of the regional GM volumes were
not associated with walking speed
in the control group (p > 0.005,
Bonferroni adjusted). Adjusted for
age, sex and body mass.
17. Hajjar et al.
[48]
2010 USA, Boston, BP
in stroke study
(?overlap with
Novak et al.)
Non-stroke group 43 Case–control
observational
study
68 (1) 44 WM, GM (global and
regional), CSF normalized
for ICV
Gait speed over
12mins at usual
pace
Study: Gait speed was not
significantly associated with
GM volume (p = 0.85), but was
significantly associated with WM
volume (B = 1.30, p = 0.03) adjusting
for age, gender, BMI and
antihypertensive use.
18. Novak et al.
[49]
2009 USA, Boston
(?overlap with
Hajjar et al.)
76 Observational
study
64.7 (7.2) 47.4 GM, WM, CSF, WMH all
as % brain tissue volume.
WMH using Wahlund
scale
Gait speed over
12mins at normal
walking pace
Study: Gait speed was significantly
associated with frontal WM
normalized for brain tissue
volume (R = 0.4, p = .003). Gait
speed was significantly associated
with frontal GM normalized for
brain tissue volume (R = 0.3, p = .01).
Adjusted for age and BMI (but
not gender). Doesn’t say about
other regional brain volumes,
ie temporal etc. WMH volumes
and PVH and punctuate scores
were not associated with gait speed
(p > 0.05).
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Table 3 Studies identified with brain structure and muscle function (Continued)
19. Moscufo
et al. [50]
2012 USA, Boston, Moscufo
study – 2 year f/u
77 Longitudinal
cohort study
84 (3.9) 40 WMH volume as % of ICV
and regional WMH burden
expressed as % of ROI
volume. At baseline and
2y f/u.
Gait speed over
2.5 metres, maximum
velocity and usual
walking speed At
baseline and 2y f/u.
Study: Total WMH burden was
significantly associated with usual
walking speed at baseline but
not at follow-up, and maximum
walking speed was not associated
with total WMH at baseline or
follow up. At baseline, regional
WMH burden in the splenium
of corpus callosum and anterior
and superior corona radiata, was
significantly associated with both
walking measures (p < 0.05) and in
addition the body of the corpus
callosum was also associated with
usual walking speed (p < 0.05). At
follow-up, WMH burden in the
splenium was significantly
associated with both walking
measures (p < 0.05) and in the
body with maximum walking
speed. Change in WMH burden,
either total or in any of the 7
regional areas, over 2 years was
not associated with a decline in
usual walking speed (p > 0.1).
Given: WMH burden is significantly
associated with lower gait speed
after adjustment for age, sex and
BMI (rho = −0.327, p = 0.0008).
WM/ICV is not significantly
associated with gait speed with
or without adjustment (p > 0.05).
GM/ICV is significantly associated
with gait speed with adjustment
for age, gender and BMI (rho= 0.232,
p < 0.05). CSF/ICV is significantly
associated with gait speed with
adjustment for age, sex, BMI
(rho = −0.285, p = 0.004).
20. Moscufo
et al. [51]
2011 USA, Boston, Moscufo
study - baseline
99 Cross-sectional
observational
study
83(4) 42.4 WM, GM, WMH and CSF
volumes all corrected for
ICC. Brain atrophy.
Regional WMH burden
expressed as % of ROI
volume.
Gait speed over
2.5metres (done
as part of SPPB)
Study: Total WMH burden (i.e. %
of ICV) correlates with gait speed
(rho =−0.288, p = 0.004). Also all
9x regional burden measurements
correlate with gait speed score too
except sup. longitudinal fasciculus.
No adjustment.
Given: See Moscufo et al. (2012) for
analysis using this dataset.
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Table 3 Studies identified with brain structure and muscle function (Continued)
21. Wolfson
et al. [52]
2005 USA, Boston, WML
and mobility
28 at baseline, 14 at
follow up
Prospective
longitudinal
observational
study
SPPB 11or12 mean
81(1.7), SPPB =<8
mean 84(3.4)
64.3 GM, WM, WMSA,
CSF, ICCV volumes
Gait velocity
over 8metres
Study: Slower baseline gait velocity
predicted more WMSA at visit 1
(p < 0.05), but not change in
WMSA volume between visit 1
and 2 (p < 0.07). Significant negative
relationship of between-visit change
in gait velocity to CSF volume
(r = 0.733, p < 0.005) and a positive
relationship of between-visit change
in gait velocity to WM volume
(r = 0.558, p < 0.05). Betas not
given. Brain volumes normalized
for ICCV according to image
processing section.
22. Guttmann
et al. [53]
2000 USA, Boston, WML
and mobility
28 (12 with SPPB
score >10 and 16 < 9)
Observational
cross-sectional
study
SPPB > 10 79(5)
SPPB < 9 83(6)
42.9 WM, WMSA, GM, CSF
(normalized for ICCV)
Gait velocity
over 8metres
Study: Gait velocity was not
significantly predicted by age
nor WMSA volume (no figures
given or p value) adjusted with
and without MMSE score.
23. Rosano
et al. [54]
2012 USA, Cardiovascular
health study
214 Longitudinal
observational
study
72.3 (3.8) 35.5 Brain volumes (GM,
WMH, Prefrontal area,
WM, CSF)
Timed 15 ft walk
at usual pace
Study: Prefrontal area volume
significantly predicted time to
walk in a stepwise forward model
(beta −0.15, p = 0.02).
24. Barnes
et al. [55]
2009 USA, Cardiovascular
Health Cognition
Study, nested within
the CVS Health Study
3375 Prospective,
population-based,
longitudinal
study
75 (no sd) 41 White matter disease
and
ventricular enlargement
Gait speed over
15 ft
Study: none, see Rosano (2012),
Rosano (2006), Rosano (2005) and
Longstreth (1996) for analysis
using the Cardiovascular Health
study dataset
25. Rosano
et al. [56]
2006 USA, Cardiovascular
health study
321 Longitudinal
observational
study mean
f/u 4 years
78.3 (no sd) 39.3 WMAs, ventricular
enlargement
Gait speed at
usual pace over
4 metres using
GaitMat II
Study: Gait speed was significantly
correlated to total WMAs (r = −.18,
p < 0.0001) and white matter
lesions in the brainstem (r = −.18,
p = 0.01). After adjusting for age,
slower gait speed was still
significantly associated with
white matter grade (p = 0.02).
Logistic regression found that
those in the lowest two quartiles
of gait speed (ie < 1.02 m/s) had
double the likelihood of having
WMH graded 3 or above (p = 0.03),
after adjustment for age, race,
gender, and prevalent clinical CVD.
VE graded >4 was not found to be
significantly predicted by gait
speed, however VE graded > 5
was, independent of age, gender,
race and presence of CVD (OR= 2.91
for 1st vs. 4th quartile, OR 3.82 for
2nd vs 4th quartile)
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Table 3 Studies identified with brain structure and muscle function (Continued)
26. Rosano
et al. [57]
2005 USA, Cardiovascular
health study
2450 Longitudinal
observational
study mean
f/u 4 years
74.4 (4.7) 43 WMH and ventricular
enlargement (graded as
minimal, moderate and
severe)
Gait speed over
15 ft at usual pace,
starting from
standing still
Study: Grade of ventricular
enlargement was associated with
baseline gait speed and mean
change in gait speed/year. Gait
speed decline was 2.5x that for
those with severe VE than minimal
VE. (p < 0.001). Grade of WMH was
associated with baseline gait
speed and mean change in gait
speed/year (p = 0.003). In both
analyses adjustment had been
made for age, sex, race and
education and CV risk factors
(BMI, systolic BP, antihypertensive
meds, internal carotid wall
thickness, and ETOH intake) and
prevalent CV disease.
27. Silbert et al.
[58]
2008 USA, Oregon Brain
Aging Study
104 Longitudinal
cross-sectional
study
85.1 (5.6) 38.5 PV WMH and s/c WMH,
total WMH, brain volume,
CSF volume, hippocampal
volume, ICV
Gait speed over
9 m. Self-selected
pace.
Study: Adjusted for age and ICV,
higher baseline total WMH vol.
was associated with increased
rate of change in timed walking
in seconds (r2 = 0.08, p = 0.0052).
This relationship became
non-significant after adjustment
for multiple comparisons to
threshold p value. PVH volume is
associated with increased rate of
change in timed walk in seconds
(r2 = 0.12, p = .0039). However,
baseline subcortical WMH vol. was
not related to change in gait
performance over time. Higher
rate of PVH accumulation is
associated with increased rate
of change of time to walk 9 m
(r2 = 0.15, p = .0453). Adjusted
for age, ICV and baseline WMH
volume:
Calculated: In an unadjusted GLM,
gait speed was predicted by
total brain, WMH and hippocampal
volume (p < 0.001). The relationship
remained significant after adjusting
for sex, age, ICV and height, for total
brain volume (t = 3.61, p = .004,
partial eta squared 4.3%) and
WMH (t = −2.80,
p = 0.006, partial eta squared 4.4%)
but not for hippocampal volume.
Kilgour
et
al.BM
C
G
eriatrics
2014,14:85
Page
13
of
35
http://w
w
w
.biom
edcentral.com
/1471-2318/14/85
Table 3 Studies identified with brain structure and muscle function (Continued)
28. Marquis
et al. [59]
2002 USA, Oregon Brain
Aging Study
108 Longitudinal
cross-sectional
study
83.2 (7.9) 37 Total brain volume,
hippocampal volume,
ICV
Gait speed over
9 m. Self-selected
pace.
Study: Negative correlation
between hippocampal volume
and time to walk 30 ft (r = −.12).
No p value given.
Calculated: See Silbert et al. (2008)
for Oregon Brain Aging Study
data analysis.
Brain structure and gait speed plus grip strength or isometric knee extension strength (IKES)
29. Rosano
et al. [60]
2010 Iceland, AGES-Reykjavik
study
795 Longitudinal
cohort study
M 75.6 (5.4)
F 75.6 (5.7)
41.1 MTR, ICV, brain parenchyma
volume, semiquantitative
subcortical WMH and PVH
and total WMH volume,
brain atrophy index
Gait speed over
6 m usual speed
and maximal
isometric knee
extension strength
Study: In men: Time to walk 6metres
predicted by WMH volume (beta
0.13, p = 0.02) but not brain atrophy
or peak height MTR (adjusted for
age and brain size as includes
measure of brain atrophy). In
women: Usual walking speed
predicted by lower MTR height
(i.e. indicating abnormal brain
tissue) (beta −0.14 (p = 0.01),
increased WMH (beta 0.12,
p = 0.003) and greater brain
atrophy (beta 0.15, p = 0.01)
(adjusted for age and brain size).
Lower muscle strength associated
with peak height MTR (p < 0.005,
beta not given).
30. Aribisala
et al. [61]
2013 UK, LBC 1936 study 694 Longitudinal
cohort study
69.5 (0.7) wave 1
and 72.5 (0.7)
wave 2
52.9 TBV, ventricular volume,
GM, NAWM and WML
at wave 2
6 metre walk (normal
walking pace) and
grip strength at wave
1 and 2
Study: Grip strength at wave 1
significantly predicts ventricular
volume at wave 2 (standardized
beta −0.10), however there was
no significant association with
other brain volumes. 6metre walk
at wave 1 predicted TBV (−0.07),
ventricular volume (0.09), NAWM
(−0.07) and WML (0.11) all p < 0.05.
Grip strength at wave 2 was
associated with ventricular volume
(−0.11) and NAWM (0.08). 6 MW at
wave 2 was associated with TBV
(−0.07), NAWM (−0.09) and WML
(0.11) all p < 0.05. Change in
physical function between wave 1
and 2 (i.e. decrease in grip strength
or increase in 6 MW) was not
significantly associated with any
brain volume measure. GM volume
did not significantly associate with
any of the physical function
variables at wave 1 or 2. All analyses
were adjusted for age, ICV, age 11
IQ, years of education, social class,
comorbidity and smoking status.
Corrected for false discovery rate.
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Table 3 Studies identified with brain structure and muscle function (Continued)
31. Rosano
et al. [62]
2011 USA, Cardiovascular
health study
643 Longitudinal
observational
study
72.1-72.6 broken
down by BP
diagnosis
31-42.7 broken
down by BP
diagnosis
WMH scale 0-9 Gait speed over 15 ft,
starting from standstill.
Grip strength of
dominant hand.
Study: none, see Rosano (2012),
Rosano (2006), Rosano (2005) and
Longstreth (1996) for analysis
using the Cardiovascular Health
study dataset.
32. Rosano
et al. [63]
2008 USA, Cardiovascular
health study
3156 Longitudinal
observational
study mean
f/u 4 years
74 (4.6) 43.2 White matter disease
score, brain atrophy
score (ventricular
enlargement)
Gait speed over 15 ft
and grip strength in
dominant hand
Study: none, see Rosano (2012),
Rosano (2006), Rosano (2005) and
Longstreth (1996) for analysis
using the Cardiovascular Health
study dataset.
33. Longstreth
et al. [64]
1996 USA, Cardiovascular
health study
3658 Longitudinal
observational
study
70.7 (no sd) 41.7 MR WMSA graded 0-9 Time to walk 15feet,
grip strength in dom
and non-dom hand
Study: Time to walk 15 ft correlated
with white matter grade (0–9)
(r = 0.153, p < 0.001), with
adjustment for age, sex and
presence of clinically silent stroke
on MRI. Same model showed no
significant associated between
grip strength in dom hand or
non-dom hand and white matter
grade (p > 0.05).
#All brain structure variables performed using MRI.
*Associations column key: Study = results published within the study; Given = associations calculated by study authors and supplied to us for this review; Calculated = study authors supplied raw data to us and we performed the analysis.
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Table 4 Studies identified with brain function and muscle structure
Author Year Country and
dataset
n Study design Mean age
(sd)
Male
(%)
Brain function Muscle
structure
Associations*
1. Berryman
et al. [65]
2013 Canada, Training
Intervention Study
48 Baseline characteristics
from a large physical
training intervention
study
70.8 (5.4) 41.67 MMSE & modified
Stroop test
LBM (DEXA) Study: none
Calculated: A GLM showed no
association between LBM and
MMSE, Stroop naming, reading
or inhibition tasks, adjusted for
sex and age. However there
was an association between
the Stroop flexibility task and
LBM (t 2.126, p = 0.039, partial
eta squared 9.3%), however after
adjusting for education and
height the effect was attenuated
(p > 0.05).
2. Bites et al.
[66]
2013 Chile 306 Retrospective study M 74.9 (61–91),
F 75.5 (69–90)
24.5 MMSE TLM, Arm LM
and Legs LM
(DEXA)
Study: none
Calculated: Authors sent one data
sheet for this study and Bunout
et al., as there is a large amount
of overlap between the studies.
N = 401, mean age 75.3 (sd 4.8),
males 28.7%. GLM performed
adjusting for sex and gender. Total
LM (t 2.38, p = 0.018, partial eta
squared 1.4%) and Leg LM (t 3.53,
p < 0.001, partial eta squared 3.1%)
were both associated with MMSE
score but Arm LM is not. After
adjusting for height the relationship
between total LM and MMSE is
non-significant and between leg
LM and MMSE is attenuated (t 2.09,
p = 0.038, partial eta squared 1.1%).
3. Bunout
et al. [67]
2005 Chile 298 RCT M 75.4 (4.8)
F 75.8 (4.7)
29.2 MMSE TLM, Arm LM
and Legs LM
(DEXA)
Study: none
Calculated: See Bites et al. 2013 for
analysis using this dataset
4. Auyeung
et al. [68]
2013 Chinese University
of Hong Kong -
4y f/u
3153 Prospective observational
study
M 71.76 (4.67)
F 72.03 (5.07)
49.7 CSI-D and MMSE ASM, LLMM,
FFM (DEXA)
Study: none
Given: CS-CSID did not predict TLM
or ASM at baseline or at 4 years (all
p > 0.05). However baseline MMSE
was associated with baseline TLM
(rho = 0.058, p = 0.002) and ASM
(rho = 0.061, p = 0.001) and at follow-
up (TLM rho = 0.058, p = 0.002, ASM
rho = 0.054, p = 0.005). MMSE at
follow up was not associated with
TLM or ASM at baseline or follow-up
(p > 0.05).
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Table 4 Studies identified with brain function and muscle structure (Continued)
5. Auyeung
et al. [69]
2011 Chinese University
of Hong Kong -
4y f/u
2737 Prospective observational
study
M 71.6 (4.58)
F 71.5 (4.85)
55.3 CSI-D and MMSE ASM (DEXA) Study: In men, low baseline ASM
predicted lower MMSE score after
4 years (B = 0.246, p < 0.01) however
after adjustment for age, years of
education and baseline MMSE it no
longer did (p > 0.05). In women,
ASM did not significantly predict
MMSE after 4 years, either before
adjustment or after (p > 0.05).
Given: see Auyeung et al. (2013) for
analysis using this dataset
6. Lee et al.
[70]
2011 Chinese University
of Hong Kong
4000 Prospective observational
study
M 72.3 (5.0)
F 72.5 (5.3)
50 CSI-D and MMSE ASM, LLMM,
FFM (DEXA)
Study: none
Given: see Auyeung et al. (2013) for
analysis using this dataset
7. Auyeung
et al. [71]
2008 Chinese University
of Hong Kong -
baseline
4000 Prospective observational
study
M 72.3 (5.0)
F 72.5 (5.3)
50 CSI-D and MMSE ASM (DEXA) Study: none
Given: see Auyeung et al. (2013) for
analysis using this dataset
8. Pedersen
et al. [72]
2012 Denmark 72
controls
Cross-sectional study Median 53
(48–60 inter
quartile range)
46 DART, WAIS-III information
subtest, TMT-A&B, Rey
Auditory Verbal Learning
Test (RAVLT), Symbol Digit
Modalities Test (SDMT), and
fluency tests
FFM (DEXA) Study: None
Calculated: FFM did not predict the
cognitive z score with or without
adjusting for BMI and childhood
intelligence (Danish Adult Reading
Test, DART). The six individual
cognitive tests were then analysed:
FFM did not predict RAVLT, SDMT,
category fluency (using animals) or
TMT-b test, with or without adjusting
for BMI and childhood intelligence
(DART). Unadjusted, there was no
significant association between the
letter fluency test (using “s”) and FFM
(P > 0.05), however after adjustment
for BMI and DART, letter fluency was
significantly associated with FFM
(t 2.34, p = 0.02, partial eta squared
7.7%). TMT-a test did significantly
predict FFM (t 3.08, p = 0.003, partial
eta squared 12.3%). After adjusting
for BMI and DART the relationship
became non-significant.
9. Magri et al.
[73]
2006 Italy 27
controls
Cross-sectional case–control
study
Controls 33.3
(7.15)
0 MMSE FFM (BIA) Study: none
Calculated: FFM did not significantly
predict MMSE (p > 0.05), adjusting for
age. Adjustments for BMI and
educational level did not significantly
affect the results.
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Table 4 Studies identified with brain function and muscle structure (Continued)
10. Lasaite
et al. [74]
2009 Lithuania 29
healthy
controls
Observational case–control
study
66.2(6.3) 0 TMT-A and B and digit
span
FFM (BIA) Study: none
Calculated: FFM does not significantly
predict TMT-A or B adjusting for
age +/− height (p > 0.05). Trend with
FFM predicting digit span (t 1.96,
p = 0.06, partial eta squared 13%) but
attenuated when adjusted for height
in addition to age (p = 0.37).
11. Liu et al.
[75]
2014 Taiwan, I-Lan
Longitudinal
Aging Study
983 Population based ageing
cohort study
65.2 (9.3) 50.6 MMSE LBM and Relative
ASM (=ASM/
height2) (DEXA)
Study: A t test comparing mean MMSE
in those with normal RASM and those
within the lowest 20 % of RASM found
a significant difference in men and
women of all ages (p < 0.05).
Given: In a MLR, RASM did not predict
MMSE after adjusting for age and sex
(beta −0.003, p = 0.940). Adjusting for
education in addition did not affect
the results.
12. Moore
et al. [76]
2012 USA, Baltimore
Longitudinal
Study of Aging
786 Longitudinal cohort study 66.3 (range
26–96)
51.9 California Verbal Learning
Test (CVLT), digit-span test,
TMT A & B
Mid-femur thigh CSA
(CT)
Study: none
Given: In a linear regression, none of
the cognitive tests predicted thigh CSA,
adjusting for age and gender. After
adjusting for age, gender and height,
the digit-span backward test became
significantly associated with thigh
CSA (beta −1.55, p = 0.024).
13. Kamijo
et al. [77]
2014 USA, FITKids
Study
37
(healthy
weight)
Cross-sectional study (case–
control substudy comparing
obese and healthy weight
children)
8.8 (0.6) 46 Kaufman Brief Intelligence
Test (K-BIT)
TLM (DEXA) Study: none
Calculated: Authors sent one data
sheet for the FITKids study as there is
considerable overlap in subjects
between the two Kamijo et al. papers
[77,78], (n = 139, mean age 8.8 (sd 0.6),
male 51.1%). A GLM found that TLM did
not predict K-BIT after adjustment for
age and gender (p > 0.05). Adjusting for
BMI in addition did not alter the results.
14. Kamijo
et al. [78]
2012 USA, FITKids
Study
126 Cross-sectional study 8.9 (0.5) 50 Kaufman Brief Intelligence
Test (K-BIT)
TLM (DEXA) Study: none
Calculated: as per Kamijo et al. [77]
*Associations column key: Study = results published within the study; Given = associations calculated by study authors and supplied to us for this review; Calculated = study authors supplied raw data to us and we
performed the analysis.
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Table 5 Studies identified with measures of brain structure or function and muscle structure or function but no associations given in paper or on request
Authors Year Country and dataset n Study design Mean age (sd) Male (%) Brain structure or
function
Muscle structure or function
Studies with brain structure and muscle structure (re: Table 2)
1. Chowdhury
et al. [79]
1994 Sweden 8 Methodology paper 35 (8) 100 Brain volume (CT) Calculated skeletal muscle
volume (CT)
Studies with brain structure and muscle function (re: Table 3)
2. Liu-Ambrose
et al. [80]
2010 Canada, Exercise RCT
in Vancouver
155 RCT, prospective over
52 weeks
69.6 (2.9) 0 Whole brain volume (MRI) Gait speed, quads strength
and muscle power
3. Nadkarni
et al. [81]
2012 Canada, Sunnybrook
Dementia Study
20 controls Cross-sectional substudy
of longitudinal study
75 (9) 40 Score on Age-Related
White Matter Change
Scale (MRI)
Self-selected speed on a
treadmill
4. Sullivan
et al. [82]
2005 USA, California, Stanford 51 Case–control study 45.2 (13.9) 100 Caudate, putamen, nucleus
accumbens and medial
septal / diagonal band
volumes and ICV (MRI)
Bilateral grip strength
Studies with brain function and muscle structure (re: Table 4)
5. Guthrie
et al. [83]
2004 Australia, The Melbourne
Women's Midlife Health
Project
1897 9 year prospective,
observational population
based sample
Median 50 0 Episodic verbal memory
using a 10 word recall task
(CERAD)
Body composition (DEXA)
6. Ellis et al.
[84]
2009 Australian Imaging,
Biomarkers and Lifestyle
(AIBL) study of aging
768 healthy
controls
Longitudinal case control
study (AD vs MCI vs
normal)
70.0 (7.0) 43 CVLT-II, Logical memory,
RCFT, digit span, digit
symbol coding, D-KEFS
verbal fluency, BNT, clock,
WTAR, Stroop.
Body composition (DEXA) in
subgroup in Perth
7. Dao et al.
[85]
2013 Canada, Exercise RCT in
Vancouver
114 Secondary analysis of
RCT data
69.4 (2.9) 0 Stroop test, MMSE Sub-total lean mass (DEXA)
8. Schwartz
et al. [86]
2013 Canada, Saguenay
Youth Study
983 Longitudinal cohort
study
M 14.9 (1.8),
F 15.1 (1.9)
48.8 Executive function and
Memory
FFM (BIA)
9. Bagger
et al. [87]
2004 Denmark, PERF study 5607 Prospective, observational
cohort study
71.1 (6.6) 0 Short Blessed Test TLM (DEXA)
10. Abellan
van Kan
[88]
2013 France, EPIDOS study 3025 Prospective multi-centre
cohort study
80.51(3.9) 0 SPMSQ Lean mass and ALM (DEXA)
11. Nourhashemi
et al. [89]
2002 France, EPIDOS study 7105 Cross-sectional study 80.3 (3.65)
(SPMSQ > =8)
0 SPSMQ for orientation,
concentration and
memory
FFM (DEXA)
12. Nourhashemi
et al. [90]
2001 France, EPIDOS study 7364 Prospective multicentre
study
Broken down
by ADLs; means
79.9-82.7 years
0 Pfeiffer’s test (aka SPMSQ) Body composition (DEXA)
13. Paolisso
et al. [91]
1997 Italy, Naples 30 (>50y), 30
(75-99y) 19
(>99y)
Observational study 44.5(1.8), 78(0.7),
102(0.8)
46.8 MMSE FFM (BIA)
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(Continued)
14. Malaguarnera
et al. [92]
2007 Italy, Sicily 66 Placebo controlled,
randomized, double-blind,
2-phase study
101(1.3) treatment,
101(1.4) placebo
31.8 MMSE Total muscle mass (BIA)
15. Jacobsen
et al. [93]
2012 Netherlands 318 RCT Mean for each arm
given range 73.4-74.0
0 15 words test and Trails
B test
BIA and DEXA
16. Genton
et al. [94]
2011 Switzerland 213 in 1999
and 112 in
2008
Cross-sectional study with
9 year f/u visit
1999 M 71.7(5.2) 1999 49.3 MMSE FFM (BIA), ASMM (DEXA) and
BCM (total body potassium)
2008 M 80.3(5.2) 2008 49.1
1999 F 73.2(5.5)
2008 F 82.2(5.6)
17. Donaldson
et al. [95]
1996 USA, Baltimore 73 Cross-sectional study 68.8 (7.2) 31.5 MMSE FFM (DEXA)
18. Bove et al.
[96]
2013 USA, Boston, Harvard 12 Cross-sectional study 31.6 (6.4) 0 Multiple tests broken
down to 5 cognitive
domains
Cross sectional area of
mid-thigh (CT)
19. Papadakis
et al. [97]
1995 USA, California, San
Francisco
104 Cross-sectional study 75.5(4.9) 100 MMSE, Trails B and DSST Lean tissue mass (DEXA)
20. Janssen [98] 2006 USA, Cardiovascular
health study
Baseline 5036 Longitudinal observational
study (over 8 years)
65-70 (42.7%), 71–76
(32.7%), 83–89
(18.2%), ≥90 (6.4%)
43.6 MMSE Whole body muscle mass (BIA)
and normalized for height to
the skeletal muscle index
(SMI, kg/m2)
21. Masley
et al. [99]
2008 USA, Florida 56 RCT Controls 43.5 (11.2),
Intervention 47.1 (9.4)
Control 39.3,
Intervention
53.6
CNS vital signs battery FFM (BIA)
22. Houston
et al. [100]
2012 USA, Health, Aging, and
Body Composition study
2641 Longitudinal cohort study 74.7 (2.9) 48.9 MMSE Lean mass (DEXA)
23. Middleton
et al. [101]
2011 USA, Health, Aging, and
Body Composition study
197 Cross-sectional study from
a 9 year longitudinal
cohort study
Separated into tertile
of activity, means
range from 73.9-75.8
Not given 3MS FFM (DEXA)
24. Koster et al.
[102]
2010 USA, Health, Aging, and
Body Composition study
2949 Cross-sectional study from
a 9 year longitudinal
cohort study
Age 70–79 at baseline 48.5 3MS Total bone-free lean mass,
trunk lean mass, appendicular
lean mass (DEXA)
25. de Rekeneire
et al. [103]
2003 USA, Health, Aging, and
Body Composition study
2926 Baseline data from a
9 year longitudinal cohort
study
Diabetes mellitis (DM)
73.6 (2.9) and non-DM
73.6 (2.9)
DM 55.9
Non-DM
46.9
MMSE and DSST Lean mass and lean soft tissue
mass (i.e. lean mass minus bone)
(DEXA)
26. de Rekeneire
et al. [104]
2003 USA, Health, Aging, and
Body Composition study
Fallers 652,
non-fallers
2398
Baseline data from a
9 year longitudinal cohort
study
Range 70-79 Fallers 41.7,
non-fallers
50.3
Teng Mini-mental State
Examination and DSST
Total muscle mass and skeletal
muscle mass in the legs (DEXA)
27. Watts et al.
[105]
2013 USA, Kansas, Brain Aging
Project
74 healthy
controls
Longitudinal case–control
study (Alzheimer’s
dementia vs. controls)
74.0 (7.2) 43 MMSE Lean mass (DEXA)
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28. Canon et al.
[106]
2011 USA, National Health and
Nutrition Examination Survey
(NHANES)
867 Cross-sectional
longitudinal study
Range 60-85 44.8 Digit-symbol coding test Lean tissue mass (DEXA)
29. Garry et al.
[107]
2007 USA, New Mexico Aging
Process Study
809 rolling
participants
(average 302
seen per year)
Longitudinal Aging study
(1979–2003)
60+ Varied
between years
40 3MS (annual), WAIS R digit
span, Fuld object memory
evaluation, Color Trails 1
and 2, clock drawing (all
less than annual)
Annual skeletal tissue mass
(DEXA)
30. Haren et al.
[108]
2008 USA, St Louis, African-
American Health Study
124 Population based
longitudinal study
56.1(4.4) 100 MMSE, TMT A&B TLM and ASM (DEXA)
31. Dvorak et al.
[109]
1998 USA, Vermont 30 Case–control study 73(7) 43.3 MMSE ASM and FFM (DEXA)
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[26]. They performed multiple linear regression and
found that after adjusting for age and fat mass, FFM pre-
dicted brain mass in men (beta 0.023, R2 5%, p = 0.01)
and women (beta 0.003, R2 6%, p = <0.0001). Fat mass
or bone mineral content did not significantly predict
brain mass in either sex. So they conclude that it is FFM
that drives the relationship between body size and brain
size not bone or fat mass. Weise et al. investigated the
associations between regional grey matter volume and
fat free mass index (FFMI = FFM/height2) [31]. They
found several areas of grey matter volume that were sig-
nificantly associated with FFMI (p < 0.01, see Table 2),
however after adjusting for percentage body fat or fat
mass only two areas remained significant (the right tem-
poral pole and bilateral ventromedial prefrontal cortex).
Association of brain structure and muscle function
Thirty three studies which included measures of brain
structure and muscle function were identified (Table 3).
The muscle function variables most commonly studied
were grip strength and gait speed. Only one study was
identified which used a different measure of muscle
function and that was maximal isometric knee extension
strength (IKES) [60]. The brain structure variables in-
clude: corpus callosum area, and volumes for total and
regional GM and WM, cerebrospinal fluid (CSF), cere-
bellum, hippocampus, basal ganglia and whole brain
volume and measures of prevalence of WMH, either
volume or scoring systems (e.g. Fazekas).
Brain structure and grip strength
The PATH through life project [32-35], the Cardiovascu-
lar Health Study [55-57,62-64], the Lothian Birth Cohort
1936 study [61], a study from japan [36] and a study
from Philadelphia [37] all looked at the relationship be-
tween grip strength and brain structure.
There are four papers identified by our search strategy
from the PATH through life project, which was set up to
track and define the lifespan course of depression, anx-
iety, substance use and cognitive ability. In one paper
from this project, Anstey et al. (2007) studied the rela-
tionship between the area of the corpus callosum (CC)
(measured in three sections: anterior, midbody and pos-
terior; and total area) and grip strength [33]. They used
the grip strength from the hand the subject wrote with
and adjusted for age, sex and ICV. They found no sig-
nificant relationship between total, anterior or posterior
CC area and grip strength however they found a positive
relationship between midbody CC area and grip strength
(beta −0.09, p < 0.05). They conclude that this is due to
the association between midbody CC and the motor cor-
tices. Another paper from the PATH through life project
studied the association between grip strength and thepercentage of WM occupied by WMH in different brain
areas [35]. They found that a larger percentage of WMH
per WM volume is associated with decreased grip
strength for both the total brain and several brain areas
(frontal, temporal, parietal, anterior horn and periven-
tricular body (all p < 0.01)). However, the amount of
WMH in the occipital lobe, the cerebellum and the pos-
terior horn was not associated with grip strength. The
2009 paper from this study further investigated the rela-
tionship between WMH and grip strength [32]. This
time they looked at the relationship in men and women
separately. They found that larger amounts of WMH
was associated with reduced grip strength, adjusting for
age, depression severity and brain atrophy index, in men
(p < 0.05) but not in women (n/s). However they com-
ment that they feel that the relationship between WMH
volume and motor function is likely to be the same in
both sexes and that their finding may be due to the dif-
ference in WMH amount between men and women in
their study population. Sachdev’s 2006 paper from this
study did not look at the relationship between motor
function and brain structure and the authors did not re-
spond to our data request [34].
The Cardiovascular Health Study (CHS) is a large, lon-
gitudinal, observational study of risk factors for cardio-
vascular disease in adults 65 years or older, which
commenced in 1989 [52]. The CHS measured grip
strength and gait speed and WMSA, however only one
paper from this study looked at the relationship between
grip strength and WMSA [64]. In this paper Longstreth
et al. (1996) performed a partial correlation which found
no significant association between grade of WMSA
(graded on a scale of 0–9) and grip strength in either
the dominant or non-dominant hand (p > 0.05) after
adjusting for age, sex and presence of clinically silent
stroke on MRI [64].
The Lothian Birth Cohort 1936 study measured grip
strength at baseline and 3 years later at which point
brain volumes were also measured [61]. It is the only
study to look at longitudinal changes in muscle strength
and brain structure. Grip strength at wave 1 predicted
ventricular volume at wave 2 (standardized beta −0.10),
however there was no significant association with other
brain volumes and grip strength at wave 2 predicted
ventricular volume (−0.11) and NAWM (0.08). There-
fore, increased grip strength was associated with less
brain atrophy in this wave. However, decreased grip
strength over 3 years was not significantly associated
with any brain volume measure.
The paper by Doi et al. used multiple linear regression
to show that grip strength is not related to brain atrophy
(beta −0.082 (SE 0.005) p = 0.54) [36]. They measured
brain atrophy by mapping the MR brain scans from their
subjects to those from healthy controls. Most studies
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of brain atrophy. No associations with the other mea-
sured brain volumes were included in the paper.
The paper by Hardan et al. looked at the association
between caudate volume and grip strength in both hands
in children and young adults [37]. They found non-
significant statistical trends using Pearson’s correlation
between total caudate volume and mean grip strength in
the right (r = −0.303, p = 0.05) and left (r = −0.28, p =
0.07) hands. The relationships are negative, therefore
there is a trend that those with larger caudate nuclei
were found to have lower grip strength in both hands.
Gait speed and brain structure
The Sydney Older Person’s Study [38], the TASCOG
study [39-41], the Three-City Study [42-45], the AGES-
Reykjavik study [60], ABC1921 study [46], WML and
mobility study [52,53], further studies from Boston
[47-51], the Cardiovascular Health Study [54-57,62-64],
the Oregon Brain Aging Study [58,59], the LBC1936
study [61] all looked at the relationship between struc-
tural brain measures and gait speed. There were 27 stud-
ies identified to include in this section, making it the
most researched association in our review. The measure-
ment of gait speed varied considerably, with studies vari-
ously using maximum speed or usual pace, and some
studies requiring a turn halfway through the measure-
ment and others not. The distance used for the measure-
ment also varied from 2.5 to 75 metres, however the
most commonly used measure was usual pace over 6
metres.
The Sydney Older Person’s Study was set up to investi-
gate the environmental, biological and social determi-
nants of healthy ageing. Within it Piguet et al. looked at
the relationship between timed walk over 5 meters, ad-
justed for lower limb arthritis, and cerebellar vermis area
(broken down into V1, V2 , V3 and total), and total cere-
bellar volume. None of the measures of cerebellar size/
volume significantly predicted the timed walk [38].
The Tasmanian Study of Cognition and Gait was set
up to examine the role of age-related brain changes in
causing problems with walking, balance and cognitive
abilities in the general community. It measured brain
volumes and usual walking speed over 4.6 metres at
baseline and 31 months [39]. They found that a greater
decline in gait speed over this period was associated with
more WM atrophy and hippocampal atrophy and
greater accumulation of WML (p < 0.05). There was a
non-significant trend with GM atrophy and decline in
gait speed (p = 0.06).
The Three-City study is a longitudinal study of the re-
lation between vascular diseases and dementia in per-
sons aged 65 years and older in France, which includes
measures of WM volume and maximum walking speedover 6 metres and a repeat walking speed test at the
fourth follow up assessment (i.e. roughly 7 years after the
first). There were four papers identified from this study
which contained reference to these variables.
Soumare et al. looked at the association between
WMH volume and both baseline walking speed and de-
cline in walking speed over the 7 year follow up period
[45]. They adjusted for age, gender, education and brain
white matter volume. They found a significantly lower
mean walking speed in those with a total WMH volume
above the 75th percentile compare to those below the
25th. They found similar relationships for both deep
WMH and periventricular hyperintensities (PVH), how-
ever further analyses revealed that PVH may have more
of an effect on walking speed than deep WMH. They
also looked at WMH volume and the decline in walking
speed over the follow up period. They found that having
a WMH volume greater than the 90th percentile, more
than doubled the risk of decline in walking speed com-
pared with subjects with lower volumes of WMH. This
finding was replicated when looking at PVH but not for
deep WMH volume. Elbaz et looked at this association
further and found that large WMH volumes were not
associated with slow walking speed among highly edu-
cated participants (OR = 0.72), but were associated
with a 2-fold-increased risk of slow walking speed
among those with low education (OR = 3.19/1.61 =
1.99) (p interaction = 0.026) [42]. Results remained un-
changed after adjustment for height, BMI, and MMSE
score.
Dumurgier et al. looked at GM volumes and gait speed
in the same cohort and found that only basal ganglia
volume (beta 0.075 (SE 0.025) p = 0.003) was signifi-
cantly associated with walking speed; driven by caudate
nucleus volume (beta 0.114 (SE 0.024) p < 0.001) [43].
All other regional GM volumes were not significantly as-
sociated with walking speed.
The authors from the Three-City study provided fur-
ther associations between the variables of interest on
written request [39-41]. They looked at the relationship
between WM volume and maximal walking speed at
baseline, and walking speed decline over 31 months
using a multiple linear regression (MLR) and found no
significant association. Finally they performed a logistic
regression between a one standard deviation increase in
WM volume and the risk of having the highest walking
speed decline, which was again not significant.
The AGES-Reykjavik study is a longitudinal cohort
study which includes an MRI brain and usual walking
pace over 6 metres [60]. The MR brain imaging included
a magnetization transfer imaging sequence, which can
be used to calculate the magnetisation transfer ratio
(MTR), which can detect normal and diseased brain tis-
sue by looking at the homogeneity of the brain tissue
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speed was predicted by WMH volume (beta 0.13, p =
0.02) but not by degree of brain atrophy or peak MTR
height (both p > 0.05) (adjusted for age and brain size)
[60]. However in women slower walking speed was asso-
ciated with: lower MTR height (i.e. indicating abnormal
brain tissue) (beta −0.14 (p = 0.01); increased WMH
(beta 0.12, p = 0.003); and greater brain atrophy (beta
0.15, p = 0.01) [60]. Additionally they comment that iso-
metric knee extension strength was found to positively
correlate with peak height MTR (p < 0.005) however they
do not give the strength of the correlation or say what it
was adjusted for.
The Aberdeen Birth Cohort 1921 study is a longitu-
dinal study which includes a measure of gait speed (self-
paced walk time over 6 metres) and a MR brain scan,
which was assessed for WMH. Lower gait speed was sig-
nificantly associated with increased WMH in the brain-
stem (p = 0.009, partial eta squared 7%), but not in the
cerebral white matter or with PVHs [46].
Seven studies were identified which met the inclusion
criteria from the Boston area in the United States. These
include two papers from the WML and mobility obser-
vational follow up study [52,53], two papers looking at
mobility, brain changes and cardiovascular risk factors at
baseline [51] and follow up at 2 years [50], two papers
conducted at the Beth Israel Deaconess Medical Centre,
where it seems there may be overlap between the study
volunteers [48,49] and a case–control study about dia-
betic peripheral neuropathy [47]. The two studies from
the WML and mobility study recorded variables at base-
line [53] and after a period of follow up (19–22 months)
[52]. The baseline paper comments that gait velocity was
not significantly predicted by WMSA corrected for ICV,
however does not give any specific figure for this ana-
lysis [53]. The follow up paper found a significant nega-
tive relationship between gait velocity and WMSA at
baseline (p < 0.05) [52], however this is in contrast to the
baseline paper and only 14 of the original 28 subjects
consented for this study. Change in gait speed between
visit 1 and 2 did not predict WMSA volume (p = 0.07).
They also state they found a significant negative rela-
tionship between change in gait speed between visits
and CSF volume (r = 0.733, p < 0.005) and a positive rela-
tionship between change in gait speed and WM volume
(r = 0.558, p < 0.05) [52]. However both the quoted cor-
relations are positive.
Moscufo et al. recruited 99 subjects to a longitudinal
study about mobility, brain changes and cardiovascular
risk factors [50,51]. Gait speed was measured using time
to walk 2.5 metres as part of the Short Physical Perform-
ance Battery (SPPB). This is a considerably shorter dis-
tance than most other measures of gait speed used. The
authors supplied Spearman partial correlations betweenthe brain volumetric variables and gait speed, which
were not described in the paper. Greater WMH burden
(rho = −0.365, p = 0.0002) and CSF volumes (rho = −0.284,
p = 0.004) are associated with slower gait speed. White
matter was not found to significantly predict gait speed,
however larger GM volume did predict faster gait speed
(rho = 0.232, p = 0.020) [51].
An analysis was made in the baseline paper, to investi-
gate whether location of WMH affected gait speed [51].
They selected 10 regions of interest (ROI), which were
neural pathways involved in sensory input or motor re-
sponse and performed a Spearman’s correlation with a
corrected significance threshold of ≤0.005 (calculated
using the Bonferroni method to adjust for multiple com-
parisons). All 10 ROI were found to significantly correl-
ate with the walking speed score at p < 0.005 (rho values
between 0.279 and 0.426), except in the superior longitu-
dinal fasciculus (p = 0.035) [51].
The follow up paper in this study, performed after
2 years, found that total WMH burden was significantly
associated with usual walking speed at baseline but not
at follow-up, and maximum walking speed was not asso-
ciated with total WMH at baseline or follow up [50]. At
baseline, regional GM WMH burden in the splenium of
corpus callosum and anterior and superior corona
radiata, was significantly associated with both usual
and maximum walking speed (p < 0.05) and in addition
the body of the corpus callosum was also associated
with usual walking speed (p < 0.05). At follow-up,
WMH burden in the splenium was significantly associ-
ated with both walking measures (p < 0.05) and in the
body with maximum walking speed. Change in WMH
burden, either total or in any of the 7 regional areas,
over 2 years was not associated with a decline in usual
walking speed (p > 0.1). However decline in walking
speed was entered as a binary variable for this analysis
(i.e. decline or no decline in walking speed over 2 years),
which may have missed a relationship between greater
WMH burden and greater declines in walking speed.
Two papers carried out their studies at the Beth Israel
Deaconess Medical Centre. One paper looked at healthy
volunteers [49] and the other looked at stroke patients
in comparison to healthy volunteers [48]. It does not ex-
plicitly state the healthy volunteers are the same for each
study, but the exclusion criteria, time period and author
list would indicate this. The first study measured gait
speed over 12 minutes at normal walking speed. MR
brain images were analysed for WMH burden and brain
volumes corrected for ICV. They found that gait speed
was correlated to frontal WM volume (r 0.4, p = 0.003)
and frontal grey matter volume (r 0.3, p = 0.01) [49].
However total WMH burden was not associated with
gait speed. It is not exactly clear why they looked at
frontal brain volumes and gait speed and not other
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paper also measured gait speed over 12 minutes and
used MR brain images. In the non-stroke group, white
matter volume was found to predict gait speed (B 1.30,
p = 0.03) but not grey matter (p > 0.05). They comment
that greater brain atrophy is associated with slower gait
speed, but this is for the whole group, so includes stroke
patients.
The final study from Boston was by Manor et al. and
quoted results from the control group [47]. They found
no association between total GM volume or regional
GM volumes and walking speed over 75 metres (p >
0.005, Bonferroni adjusted). They were being compared
to subjects with diabetic peripheral neuropathy in this
study. No results for WM or CSF were reported in the
study.
Seven studies from the Cardiovascular Health Study
(CHS) met our criteria for inclusion. However three of
the studies did not contain any associations between the
variables of interest and the study authors did not supply
the raw data or correlations [55,62,63]. The first study
used gait speed measured over 15 feet, and MR brain
images were used to measure ventricular enlargement
(VE) and WMH both of which were recorded on a 10
point scale (0–9). Both greater ventricular enlargement
(p < 0.001) and greater WMH burden (p = 0.003) were
associated with slower baseline gait speed and greater
decline in gait speed over the 4 year follow up period
[57]. Indeed, after adjusting for baseline performance,
those with severe VE were found to have 2.5x the de-
cline in gait speed compared to those with minimal VE
at baseline. The model included adjustment for age, sex,
race and education.
The next study looked at a subset of the CHS who had
undergone two MR brain scans, separated by roughly
5 years, and a MMSE and had undergone assessment on
the GaitMat, a 4 metre long instrumented walking sur-
face [56]. THE MR brain scans were classified as
above, but given binary cutoffs for the analysis of
WMH grade ≥3 or <3 and VE >4 or <4 for some of the
analyses. Gait speed was correlated with WMH grade
(r = −0.18, p < 0.0001) and with WMH in the brain-
stem (r = −0.18, p < 0.01). Logistic regression was used
to analyse the relationship further and gait speed was
separated into quartiles. This showed that those in the
lowest two quartiles of gait speed (i.e. < 1.02 m/s) had
double the likelihood of having WMH graded 3 or
above (p = 0.03). VE graded >4 was not found to be
significantly predicted by gait speed, however VE graded
> 5 was significantly predicted by gait speed (OR= 2.91 for
1st vs. 4th quartile, OR 3.82 for 2nd vs 4th quartile) [56].
Longstreth et al. is mentioned in the above section on
grip strength and brain structure, as this was also stu-
died in this paper [64]. Gait speed was again measuredover 15 feet and WMH burden was scored 0–9 on MR
brains scans. Time to walk 15 feet was found to correlate
with WMH grade (partial correlation coefficient 0.153,
p < 0.001, adjusting for age, sex and presence of clinical
silent stroke on MR brain) [64]. The population in this
study and the study by Rosano et al. [57] overlap consid-
erably and only appear to differ in the time they were
still in the study and the particular inclusion and exclu-
sion criteria for that part of the study.
In a separate paper, Rosano et al. found that prefrontal
area volume significantly predicted time to walk in a
stepwise forward model (beta −0.15, p = 0.02) [54]. This
relationship was attenuated when adjustment was made
for DSST score, which is a measure of processing speed.
They conclude that smaller prefrontal area volume may
contribute to slower gait speed through slower informa-
tion processing.
The final two studies identified are both from the Ore-
gon Brain Aging Study (OBAS) [58,59]. OBAS I is a pro-
spective study commenced in 1989 of healthy older
adults age 65 years or older at the initial assessment, a
second arm was added in 2004, OBAS II, with less strin-
gent exclusion criteria and these subjects were 85 or
older at the start of the study. The first paper by
Marquis et al. (2002), looked at the correlation of timed
walk, measured at self-selected pace over 9 metres,
against brain volumes. Hippocampal volume was found
to negatively correlate with timed walk (partial r = −0.12),
however no significance value was given and it did not ex-
plicitly state what was adjusted for in the correlation [59].
The correlation between TBV and timed walk was <0.1.
The other OBAS paper, by Silbert et al. (2008), found that
a higher baseline total WMH volume was associated with
a greater increase in timed walk over follow up (R2 = 0.08,
p = 0.0052), the average follow up was 9.1 years [58]. They
then looked at whether location of WMH mattered and
found that whilst periventricular (PV) WMH volume was
associated with a greater change in timed walk over follow
up (R2 = 0.12, p = 0.0039), a higher subcortical WMH vol-
ume was not. These analyses were adjusted for age and
ICV. They next looked at change in WMH volume with
time and found that a higher rate of accumulation of PV
WMH was associated with a greater increase in timed
walk (R2 = 0.15, p = 0.0453). However there was no rela-
tionship described between subcortical or total WMH ac-
crual and change in timed walk. Further data from the
study was requested, which was kindly provided. Baseline
data from all subjects from OBAS I and II who had had a
MRI brain scan and a timed walk at baseline was used to
perform our analysis (n = 176).
GLMs were performed to investigate the relationship
between brain structures and gait speed, calculated in
metres per second for the analysis. In an unadjusted
model, gait speed was predicted by TBV, hippocampal
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for age, sex, ICV and height, TBV (t 3.61, p = 0.004, par-
tial eta squared 4.3%) and WMH (t −2.80, p = 0.006, par-
tial eta squared 4.4%) significantly predicted gait speed,
but hippocampal volume did not (p > 0.05).
Association of brain function and muscle structure
Fifteen papers were identified which looked at brain
function and muscle structure: DEXA was used in eleven
of the studies; BIA in two; and CT for thigh muscle CSA
and MRI for neck muscle CSA in the final two papers
(Table 4). Measures of brain function were the MMSE,
the Community Screening Instrument of Dementia (CSI-D),
Trail Making Test (TMT) A and B, digit span and a meas-
ure of global cognitive performance (using z scores from
multiple cognitive tests). The studies included the Kansas
Brain Aging Project [28-30] and the MHEM study [27], both
mentioned in the above section, and studies from Canada
[65], Chile [67], the Chinese University of Hong Kong
[69,71],Denmark [72], Italy [73], Lithuania [74], Taiwan
(the I-Lan Longitudinal Aging Study, ILAS) [75], and from
the USA, the Baltimore Longitudinal Study of Aging [76]
and the FITKids Study [77,78].
From the Kansas Brain Aging Project, Burns et al.
(2010) found a relationship between both MMSE (beta
0.11, p = 0.009) and global cognitive performance (beta
0.12, p = 0.007) and TLM, again grouping AD and con-
trol subjects together [29]. They state that in this rela-
tionship if the AD subjects are removed from the
analysis the results are attenuated, but do not show any
results for this. A GLM was performed on the data from
the non-demented group supplied to us by the study au-
thors, and we found that neither the global cognitive
performance score nor MMSE was predicted by TLM
adjusting for age and sex. Adjusting for height and edu-
cation did not affect this.
The MHEM study used 9 different cognitive tests,
which they reduced to two factors using principal com-
ponents analysis [27]. Total neck muscle CSA did not
significantly predict variance in either the memory factor
or the cognitive processing factor (p > 0.05), however,
it did predict 10% of the variance in the NART score
(t = −2.12, p < 0.05). The NART score is a measure of
childhood intelligence and the authors comment that
the finding is the opposite of what they hypothesized,
as they found that lower childhood intelligence is as-
sociated with larger neck muscle size in old age.
Berryman et al. supplied the baseline data from their
physical training intervention trial. Subjects had performed
a MMSE and modified Stroop test and underwent a DEXA
scan at baseline [65]. A GLM was performed which
showed no association between LBM and MMSE or the
Stroop naming, reading or inhibition tasks. However there
was an association between the Stroop flexibility task andLBM (t 2.126, p = 0.039, partial eta squared 9.3%), however
after adjusting for education and height the effect was at-
tenuated (p > 0.05). This effect was in the opposite direc-
tion than might be expected, i.e. bigger muscle mass is
associated with a worse score (the Stroop test is measured
in seconds to perform the task).
The two papers from Chile are a study by Bunout
et al. which includes baseline data for a randomized con-
trolled trial (RCT) investigating an exercise intervention
in the elderly [67] and a paper by Bites et al. which used
baseline trial data from several studies, including the
study by Bunout et al., held on their University database
[66]. The authors sent one data sheet for both studies as
there is a large amount of overlap between the studies
(overlap n = 203). A GLM was performed which showed
total LM (t 2.38, p = 0.018, partial eta squared 1.4%) and
leg LM (t 3.53, p < 0.001, partial eta squared 3.1%) were
both associated with MMSE score but arm LM is not.
After adjusting for height the relationship between TLM
and MMSE became non-significant and between leg LM
and MMSE is attenuated (t 2.09, p = 0.038, partial eta
squared 1.1%). Therefore it seems that leg LM is driving
the relationship between total LM and MMSE.
Four papers from the Chinese University of Hong
Kong were identified which used data from a large pro-
spective longitudinal study looking at bone mineral
density in older Chinese adults to assess the relationship
between physical and cognitive function [68-71]. They
used two measures of cognitive function; the MMSE and
the cognitive score from the Community Screening In-
strument for Dementia (CS-CSID). Only one of the pa-
pers included the associations between the cognitive
tests and muscle mass [69]. They found that in men, but
not in women, lower appendicular skeletal mass (SM) at
baseline predicted lower MMSE at follow up (for a
2.54 kg increase in appendicular SM, there would a
0.246 change improvement in MMSE, p < 0.001). How-
ever after adjustment for age, years of education and
baseline MMSE, the relationship became non-significant
(P > 0.05) [69]. The authors from this study kindly sup-
plied further analyses of their data upon our request.
They performed Spearman’s partial correlations,
adjusting for age and sex. There was no significant rela-
tionship between baseline CS-CSID and total LM or ap-
pendicular LM at baseline or 4 years. However baseline
MMSE predicted both baseline total LM (partial rho
0.058, p = 0.002) and appendicular LM (partial rho
0.061, p = 0.001) and 4 years follow up total LM (par-
tial rho 0.058, p = 0.002) and appendicular LM (partial
rho 0.054, p = 0.005). However, the effect size is small.
They also looked at the whether those with lower
MMSE at follow up had lower muscle mass at baseline or
follow up but found no significant associations (p > 0.05)
[69]. Unfortunately the study authors did not supply data
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change in muscle mass over the four year follow up which
would be very interesting in such a large study population.
Pedersen et al. investigated cognition and physical fit-
ness in normal controls, subjects with impaired glucose
tolerance and type 2 diabetes [72]. They supplied the
raw data for their control group to be analysed. Subjects
underwent DEXA for FFM and six cognitive tests (a cog-
nitive z score was computed as a marker of general cog-
nition). FFM did not predict the cognitive z score with
or without adjusting for BMI and childhood intelligence
(Danish Adult Reading Test, DART). The six individual
cognitive tests were then analysed. There was no associ-
ation between FFM and most of the individual cognitive
tests. Also, unadjusted there was no significant associ-
ation between the letter fluency test (using “s”) and
FFM (P > 0.05), however after adjustment for BMI and
DART, letter fluency was significantly associated with
FFM (t 2.34, p = 0.02, partial eta squared 7.7%). Letter
fluency is a test of executive function and this may in-
dicate that change in this type of cognition with age is
associated with FFM in older age. TMT-A test did signifi-
cantly predict FFM (t 3.08, p = 0.003, partial eta squared
12.3%), but after adjusting for BMI and DART the rela-
tionship became non-significant. The TMT-A test is a
measure of processing speed.
Magri et al. (2006) performed a cross-sectional study
looking at postmenopausal women and HRT, however
their study also contained a control group of young
healthy women which were used for our analyses after
the study authors kindly supplied their data [73]. A
GLM was performed with MMSE as the outcome/
dependent variable and FFM as the predictor/independ-
ent variable as measured by BIA. FFM did not signifi-
cantly predict MMSE after adjustment for age (p > 0.05)
[73]. Adjustments for BMI and educational level did not
further affect these results.
Lasaite et al. performed an observational case–control
study which looked at women with osteoporosis and
healthy controls [74]. The study data for the healthy
controls was supplied to us on request. The cognitive
measures were the TMT-A and B and a digit span test.
FFM was measured using BIA. A GLM was performed
on the available data. FFM did not predict TMT-A or B
adjusting for age +/− height (p > 0.05). There was a non-
significant trend with FFM predicting digit span adjust-
ing for age (t 1.96, p = 0.06, partial eta squared 13%),
however when adjusted for height too, the relationship
was attenuated (p = 0.37).
The I-Lan Longitudinal Aging Study is an ageing co-
hort study in Taiwan [75]. Within the study they per-
formed a t test comparing mean MMSE in those with a
normal relative appendicular skeletal mass (RASM =
ASM/height2) with those in the lowest 20% for RASM,and they found a significant difference in both men and
women. They also supplied the results of a linear regres-
sion on our request for further data, which showed that
RASM did not predict MMSE after adjusting for age
and sex (beta −0.003, p = 0.940). This may mean there is
a non-linear relationship between cognition and muscle
mass.
The Baltimore Longitudinal Aging Study is a large lon-
gitudinal cohort study, in which the subjects underwent
four cognitive tests and had a mid-femur CT for thigh
CSA [76]. No associations between the cognitive tests
and thigh CSA were included in the study, but the au-
thors sent the results of a MLR they had performed.
They found that none of the cognitive tests predicted
thigh CSA, adjusting for age and gender. After adjusting
for age, gender and height, the digit-span backward test
became significantly negatively associated with thigh
CSA (beta −1.55, p = 0.024), meaning those with bigger
thigh muscles perform better on the test (a higher score
is better in the digit span tests).
The final study which looked at cognition and muscle
structure is the FITKids study based in Illinois, USA
[77,78]. Two papers from this study were identified;
however there were no relevant associations in the pa-
pers and the study authors kindly provided us with the
raw data on which to perform an analysis. As the sub-
jects were all from the same study the authors provided
us with one dataset for the study. We performed a GLM
which found that TLM did not predict the Kaufman
Brief Intelligence Test, used to assess IQ.
Discussion
This systematic review looked at the evidence for
whether: a) brain structure is related to muscle struc-
ture, b) brain structure is related to muscle function and
c) brain function is related to muscle structure in
healthy humans over the life course.
Brain volumes and muscle mass
The relationship between brain structure and muscle
structure was first reviewed (see Table 6 for summary).
Three studies tested for an association between whole
brain volume and muscle mass; the three papers from
the Kansas Brain Aging Project are treated as one study
[26-30]. Two studies found a positive association be-
tween WBV and muscle mass [26,27] and one study
found no significant association [28-30]. However, this
study found a significant positive association between
WM volume and FFM but no association between GM
volume and FFM [28-30]. A different study looked at re-
gional GM volume and found four areas negatively asso-
ciated with FFM but found most areas to have no
association with FFM [31]. Two studies found no associ-
ation between hippocampal volume and muscle mass
Table 6 Number of studies of brain structure and muscle structure, direction of effect and number of subjects
Negative association (n) No association (n) Positive association (n) References
Whole brain size and muscle size - 1 (70) 2 (311) [26-30]
White matter volume and muscle size - - 1 (70) [28-31]
Grey matter volume and muscle size 1 (76)* 2 (146)* - [28-31]
Hippocampal volume and muscle size - 2 (121) - [27-30]
Cerebellar volume and muscle size - 1 (51) - [27]
Ventricular volume and muscle size - 1 (51) - [27]
*This study found negative associations between some areas of grey matter volume (the right temporal pole and bilateral vmPFC) and muscle size but found the
majority of GM areas had no association.
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cerebellar volume and muscle size and found no associ-
ation either [27]. Four of the studies were of older adults
and two were of younger adults, and it may be that the
relationship between brain and muscle structure varies
over the life course. Furthermore if there is a relation-
ship between whole brain volume and muscle size it
looks like it may be regional brain volume that drives
this relationship rather than total volume. The studies
are all cross-sectional and a large longitudinal study is
needed to explore these relationships further.
Brain structure and muscle function
Next evidence for an association between muscle func-
tion and brain structure was reviewed. Muscle function
was either grip strength (5 studies, see Table 7 for sum-
mary) or gait speed (13 studies, see Table 8 for sum-
mary) apart from in one paper where isometric knee
extensor strength (IKES) was used [60].Table 7 Number of studies of brain structure and grip streng
Negative association (n
Grip strength and whole brain volume -
Grip strength and WM volume -
Grip strength and GM volume -
Grip strength and caudate volume -
Grip strength and ventricular volume/brain
atrophy
2 (804)
Grip strength and WMH 1 (478)
Change in grip strength over f/u and whole
brain volume
-
Change in grip strength over f/u and WM
volume
-
Change in grip strength over f/u and GM
volume
-
Change in grip strength over f/u and
ventricular volume
-
Change in grip strength over f/u and
WMH volume
-
aAt wave 1 in this study there was no association and at wave 2 there was a positivBrain structure and grip strength
Only one study looked at the relationship between whole
brain, GM or WM volume and grip strength [61]. There
were no significant associations except for a positive re-
lationship between WM volume and grip strength at
wave 2 (age 73) [61]. This could mean that the relation-
ship between WM volume and grip strength only be-
comes important with age, once a volumetric threshold
is passed. Another study found no association between
caudate volume and grip strength [37]. However the
basal ganglia may be expected to play less of a role in
grip strength than in gait speed. Two studies found a
negative association with markers of brain atrophy and
grip strength [36,61], however one of these studies also
looked at change in grip strength over 3 years and found
no association with ventricular volume (a marker of
brain atrophy) [61]. This means that whilst cerebral atro-
phy and grip strength appear to be associated, decline
in grip strength does not predict cerebral atrophy. Ath, direction of effect and number of subjects
) No association (n) Positive association (n) References
1 (694) - [61]
1 (694)a 1 (694)a [61]
1 (694) - [61]
1 (41) - [37]
- - [36,61]
2 (4352) - [35,61,64]
1 (694) - [61]
1 (694) - [61]
1 (694) - [61]
1 (694) - [61]
1 (694) - [61]
e association [61].
Table 8 Number of studies of brain structure and gait speed, direction of effect and number of subjects
Negative association (n) No association (n) Positive association (n) References
Gait speed and whole brain volume - - 2 (885) [58,59,61]
Gait speed and WM volume - 2 (1587) 3 (813)b [42,48-50,61]
Gait speed and GM volume - 4 (2449)c 3 (367)b,d [43,47-50,54,61]
Gait speed and hippocampal volume - 1 (191) - [58,59]
Gait speed and cerebellar volume - 1 (111) - [38]
Gait speed and WMH volume 7 (7145)e 4 (278)e,f - [45,46,49,50,52,53,56-61,64]
Gait speed and CSF volume/ventricular
volume/brain atrophy
3 (3221)g 2 (1489)g - [50,56,57,60,61]
Gait speed and WMH progression
over f/u
- 1 (14) - [52]
Change in gait speed over f/u and whole
brain volume
- 1 (694) - [61]
Change in gait speed over f/u and
WM volume
- 2 (1622) - [42,61]
Change in gait speed over f/u and
GM volume
- 1 (694) - [61]
Change in gait speed over f/u and
CSF/ventricular volume
- 1 (694) 1 (2450) [57,61]
Change in gait speed over f/u and
WMH volume
- 1 (694) 2 (4152) [45,57,61]
Change in gait speed over f/u and
WM atrophy
- - 1 (225) [39]
Change in gait speed over f/u and
GM atrophy
- 1 (225) - [39]
Change in gait speed over f/u and
hippocampal atrophy
- - 1 (225) [39]
Change in gait speed over f/u and
WMH progression
- 1 (77) 1 (225) [39,50]
bone study only looked at frontal WM/GM volume not total WM volume [49].
cbasal ganglia volume was positively associated with gait speed in this study [43].
done study only looked at prefrontal area volume within GM [54].
ethis study found usual walking speed was negatively associated with WMH but that maximum walking speed was not [50].
fexcept brainstem WMH which were negatively associated with gait speed in this study [46].
gat wave 1 there was a negative association and at wave 2 there was no association in this study [61].
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explain this relationship further.
One study found an association between WMH and
grip strength [35]. They found that location of the
WMH is important, with some brain areas correlating
with grip strength and others not [35]. On looking at the
data separated by sex, this relationship persisted in men,
but not women, but the study authors think this is due
to a sex difference present in their study population,
with the men having higher volumes of WMH [32]. Two
larger studies found no association between WMH and
grip strength, however one of these studies used a visual
rating scale from 0–9 to measure WMH, which may lead
to differing results than using WMH volumes [61,64]. The
other study also looked at change in grip strength over
3 years and WMH volume at follow up and found no as-
sociation [61]. WMH are known to predict dementia andcerebrovascular disease but their relationship to physical
function is less well understood [110].
Brain structure and gait speed
Two studies found a positive association between WBV
and gait speed [58,59,61], whereas studies investigating
the relationship between WM and GM volume and gait
speed found less unanimous results. Three studies found
a positive association between WM volume and gait
speed [48,49,61] and two studies found no association
[42,50]. Four studies found no association between GM
volume and gait speed [43,47,48,61] but three studies
found a positive relationship [49,50,54]. There was no
evidence that hippocampal volume or cerebellar volume
were associated with gait speed [38,58,59]. It may be that
specific sub-regions of the white and grey matter are as-
sociated with gait speed, for example one paper found
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speed but no association with total GM and gait speed.
Further studies looking at regional brain areas will help
to clarify these relationships. Five studies looked at
markers of brain atrophy and gait speed; two found a
negative association (i.e. more atrophy associated with a
slower gait speed) [50,56,57] and one found no associ-
ation [60], with one finding an association at wave 1 but
not at wave 2 [61].
No association was found between change in gait
speed over follow up and whole brain, WM and GM vol-
ume (mean length of follow up in each study, 3 and
7 years) [42,61]. However one large study did find an as-
sociation between ventricular volume and change in gait
speed over follow up (mean 4 years) [57] but another
study found no association (mean follow up 3 years)
[61]. Only one study looked at the relationship between
change in gait speed and change in brain structure over
time (mean follow up 30.6 months) [39]. They found a
positive association between change in gait speed and
WM and hippocampal atrophy but no association with
GM atrophy. The well-established relationship between
cognitive decline and gait speed and cognitive decline
and brain atrophy could underpin the possible relation-
ship between brain atrophy and gait speed [4-8]. It is in-
teresting that the only study to look at both variables in
a longitudinal study found significant associations be-
tween brain structure and gait speed and further studies
like this are needed.
Eleven studies were found which looked at gait speed
and WMH, making it the most studied relationship in
our review. Seven of these studies found that greater
levels of WMH were associate with slower gait speed
[45,50,52,56-61,64], but four other smaller studies foundTable 9 Number of studies of cognition and muscle size, dire
Negative association
Muscle size and global cognitive score -
Muscle size and MMSE -
Muscle size and California Verbal Learning Test -
Muscle size and CSI-D -
Muscle size and digit span -
Muscle size and Kaufman Brief Intelligence Test -
Muscle size and modified Stroop test -
Muscle size and NART 1 (51)
Muscle size and TMT-a -
Muscle size and TMT-b -
hLeg LM was associated with muscle size but not total LM or arm LM in this study [
iIn an MLR there was no association between MMSE and FFM but when comparing
study found a significant difference [75].
jDigit span forwards unadjusted and adjusted was not associated with thigh muscle
muscle CSA in this study [76].no association [46,49,50,53]. Two of these studies found
that this is primarily due to the volume of PVH and not
subcortical WMH lesions [45,58] and two papers found
that volume of brainstem WMH was associated with gait
speed [46,56]. One small study (n = 14) found no associ-
ation between gait speed and WMH progression over
follow up (19–22 months) [52]. However, change in gait
speed was found to be associated with WMH volume in
two large studies [45,57] with another study showing no
association [61]. Two studies looked at change in both
variables; one found that greater decline in gait speed
was associated with greater WMH progression [39],
whereas the other found no association [50]. Further
studies looking not just at total WMH volume but their
rate of accumulation and location within the brain, and
their association with gait speed should help clarify this
area.
Cognitive function and muscle mass
Nine studies were found which looked at cognitive func-
tion and muscle structure. Table 9 shows the main re-
sults from these studies. Three studies looked at a
measure of global cognitive performance (a composite
score of several tests used in their study) and muscle size
and all 3 found no association [27,28,72]. The Kaufman
Brief Intelligence Test can also be used as a marker of
general cognition and it too found no association with
muscle size [77,78]. Seven studies looked at muscle size
and MMSE score, which is a useful screening tool for
dementia but is not a robust test of cognitive function.
Four of the studies found no association between MMSE
and muscle mass [28,65,73,75] and one found an asso-
ciation but with a very small effect size [68]. However
in one study which showed no association betweenction of effect and number of subjects
(n) No association (n) Positive association (n) References
3 (193) - [27,28,72]
5 (1434)h,i 2 (3459)h [28,65,66,68,73,75]
1 (786) - [76]
1 (3153) - [68]
2 (815)j - [74,76]
1 (139) - [77,78]
1 (48) - [65]
- - [27]
3 (887) - [72,74,76]
3 (887) - [72,74,76]
66].
subjects with normal RASM and those within the lowest 20% of RASM this
CSA, but adjusted backwards digit span was negatively associated with thigh
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mal RASM and those within the lowest 20% of RASM
this study found a significant difference in mean
MMSE [75]. Several of the included studies did not in-
clude those with cognitive impairment and it may be
that an association does exist between MMSE and
muscle size but in a non-linear relation, affecting the
frailer older adult more, but that it was not picked up
in these studies due to the method of analysis in a lin-
ear regression. Overall though in healthy individuals it
seems that no such association exists. The final study
found an association between leg LM and MMSE but
not between total or arm LM [66]. Sarcopenia is
known to affect leg and arm muscles differently which
perhaps explains this effect [111]. Another screening
tool for dementia, the cogscore part of the CSI-D, also
found no association with muscle mass [68]. It is well
established that gait speed and cognition are associated
in older age and these results appear to show that
muscle size is not a driving force behind this relation-
ship [4-6].
With regard to the individual cognitive tests (which
measure processing speed and executive function), there
were no significant associations [65,72,74,76], except for
the NART (a measure of childhood IQ, which showed a
negative association with neck muscle CSA [27]. The au-
thors comment that perhaps subjects with higher cogni-
tion are more likely to have sedentary jobs and therefore
more likely to lose their muscle mass over time. None of
the studies looking at cognition and muscle size con-
tained longitudinal associations therefore whilst these re-
sults appear to support no association between muscle
mass and cognition; it may be that longitudinal data
would show an association, whereby those that lose
more muscle with age have a sharper slope of decline in
their cognition also. Longitudinal studies will help to
elucidate these complex relationships further.
Limitations
In the review protocol the decision was made to write to
study authors for relevant associations or data that were
not given in the study but could be calculated using the
recorded variables. This expanded the number of articles
included in the review and the scope that they covered,
however this may have led to some bias in which articles
responded to the request and therefore what was re-
ported, as study authors who found an association may
have been more likely to reply. Of the 79 articles written
to 59 replied therefore 25% did not respond. However
the studies that did respond included both those which
showed a significant association and those that did not.
The associations which were sent to us and the associations
performed by us have not undergone peer review (e.g. for
variable selection when adjusting the models), however wehave included this information in our review and the statis-
tical technique used to remain as transparent as possible.
The studies included in the review used a wide variety
of techniques to record the variables of interest which
means it is difficult to compare them (e.g. in a meta-
analysis). Gait speed for example was recorded over
multiple lengths, using automated and manual tech-
niques and different levels of speed (i.e. maximum or
usual pace). The large differences in how gait speed was
measured combined with the fact that over longer dis-
tances it can become a test of cardiovascular fitness etc.
more than a test of muscle function, makes it difficult to
compare the results of these studies directly. Hopefully
more standardized testing will come about in the wake
of resources like the NIH toolbox which includes a pro-
forma for measuring gait speed [112].
When looking at the relationship between brain size
and muscle size or function it is important to make sure
that the size of the individual being studied is not acting
as a confounding factor (i.e. that large people have large
brains and large muscles). This meant that it was im-
portant to ensure that some measure of body size had
been adjusted for in each association (e.g. ICV, height,
BMI). In most of the studies we looked at this occurred
but in some it did not and this may lead to a false rela-
tionship being reported.
A relatively wide range of ethnicities are represented
in the study, however Caucasian subjects were by far the
most commonly studied and there were no studies in-
cluding those of Arabic or Indian ethnicity. Also most of
the studies used subjects in their sixties, seventies or
eighties, meaning the validity of our findings for other
age groups, particularly children and adolescents is
limited.
Finally, while a few of the studies included longitudinal
data, it would be very useful to have more studies look-
ing at the relationships over time as these may be able
to highlight potential modifiable factors.
Conclusions
An increasing body of research has now linked brain
function (cognition) and muscle function (e.g. gait speed)
[4-8], however less well studied is the role of muscle and
brain structure in this relationship. This systematic review
looks at the evidence for whether: brain structure is re-
lated to muscle structure; brain structure is related to
muscle function; and brain function is related to muscle
structure in healthy humans across the lifecourse.
The review found evidence of a positive association
between whole brain volume and total white matter vol-
ume with muscle size and evidence that some areas of
regional grey matter volume (right temporal pole and bi-
lateral vmPFC) are negatively associated with muscle
size [26-31].
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tween grip strength and whole brain volume, however
there was some evidence of a positive association be-
tween grip strength and WM volume. Markers of brain
ageing, that is brain atrophy and greater WMH accumu-
lation, were associated with grip strength [35,36,61]. Un-
like grip strength, there is evidence that gait speed is
positively associated with whole brain volume; this rela-
tionship may be driven by total WM volume or regional
GM volumes, specifically the hippocampus [58,59,61]. Like
grip strength, gait speed is also associated with markers of
brain aging; WMH accumulation, brain atrophy and WM
atrophy all show evidence of either a temporal association
with gait speed or change in gait speed with time, with
PVH and brainstem WMHs playing a particularly import-
ant role, but not subcortical WMH [45,57].
The evidence overwhelmingly points to no association
between cognition and muscle size, except in the case of
MMSE where it is mixed, but MMSE is more a screen-
ing tool for dementia than a true marker of cognitive
function [27,28,65,66,68,72,73,75]. Longitudinal studies
are now needed to explore these relationships over time,
which will allow a better understanding of the potential
causal relationships.
Appendix 1 Medline Search
1. brain/ or exp brain stem/ or exp cerebral ventricles/
or exp limbic system/ or exp mesencephalon/ or
exp prosencephalon/ or exp rhombencephalon/
2. (brain adj3 volume).tw.
3. white matter.tw.
4. mental processes/ or cognition/ or cognitive
reserve/ or comprehension/ or executive function/
or higher nervous activity/ or maze learning/ or exp
memory/ or thinking/ or decision making/ or
judgment/ or problem solving/
5. Intelligence/
6. exp aptitude tests/ or exp neuropsychological tests/
7. cognitive function.tw.
8. muscles/ or muscle, skeletal/ or abdominal
muscles/ or rectus abdominis/ or deltoid muscle/ or
neck muscles/ or pectoralis muscles/ or psoas
muscles/ or quadriceps muscle/ or rotator cuff/
9. Body Composition/
10. muscle cross sectional area.tw.
11. exp Muscular Atrophy/
12. exp Muscle Strength/
13. exp Walking/
14. muscle power.tw.
15. Physical Fitness/
16. physical performance.tw.
17. 1 or 2 or 3
18. 4 or 5 or 6 or 719. 8 or 9 or 10 or 11
20. 12 or 13 or 14 or 15 or 16
21. 17 and 19
22. 17 and 20
23. 18 and 19
24. 21 or 22 or 23
25. limit 24 to humans
26. limit 25 to case reports
27. 25 not 26
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